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Hydrocarbon solvents are widely used in the production of paints,
adhesives, dyes, polymers, plastics, textiles, printing inks, agricultural products and
pharmaceuticals. While the neuropathic potential of aliphatic solvents was shown
in the 1970s, little is known about the neuropathic potential of aromatic solvents.
The present study examines such solvents, 1 ,2-diethylbenzene (DEB) and
its metabolite 1,2-diacetylbenzene (DAB), to determine (a) the neuropathological
evidence for peripheral neuropathy in rodents treated with 1,2-DAB, (b) the
neurochemical basis for the neurotoxic properties of this compound, and (c) the
structural requirements for nerve fiber damage. The properties of 1,2-DAB and 2,5-
hexanedione (HD) are also compared.
A key finding of this thesis is that 1,2-DAB induces a 2,5-HD-like pattern
of nerve damage of motor and sensory axons with focal swellings containing
neurofilaments. Whereas nerve damage begins distally in 2,5-HD intoxication,
with 1,2-DAB treatment axonal swellings begin intraspinally and in the proximal
ventral roots of motor nerve fibers.
A second key finding is the reactivity of 1,2-DAB with amino acids,
notably lysine, a property that is shared with 2,5-HD. 1,2-DAB and 2,5-HD react
with amino acids and proteins to form blue and yellow chromophores, respectively.
Redacted for PrivacyRelative to 2,5-BID, 1,2-DAB is three orders of magnitude more reactive in forming
high-molecular-weight species.
1,2-DAB treatment of spinal cord slicesin vitroand intact sciatic nerve
in vivoshowed that neurofilament proteins react more readily than beta-tubulin.
The heavy and medium subunits of neurofilament protein were more reactive than
the light subunit. The reactivity of these four axonal proteins was in proportion to
their lysine content. These data are consistent with selective accumulation of
neurofilaments in giant axonal swellings.
In summary, these studies have shown a relationship between the
chromogenic and neuropathic properties of two gamma-diketones, one aliphatic
(2,5-HID) the other aromatic (1,2-DAB). These studies are relevant to occupational
and public health for at least two reasons. First, urinary chromogens generated by
neuropathic aliphatic and aromatic hydrocarbons could serve as biological markers
of exposure to solvents with neuropathic potential, and second, other chromogenic
solvents (such as tetralin) should be considered for neuropathic potential.© Copyright by Min-.Sun Kim
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Chapter 1
General Introduction
Organic solvents are used widely in industry and in everyday life; they are
found in everything from paints to cosmetics to drugs to gasoline. Many organic
solvents have been reported to be carcinogenic and hazardous for the reproductive
system. They also pose a particular threat to the nervous system, which controls
vital bodily functions and possesses a low regeneration capacity. Various solvent
chemicals and mixtures are reported as chronic neurotoxicants (Spencer and
Schaumburg, 1985).
This dissertation examines 1,2-diacetylbenzene (DAB), the putative
metabolite of the chromogenic, neurotoxic organic solvent, 1 ,2-diethylbenzene
(DEB). The various studies seek to determine: (a) the neuropathological evidence
for peripheral neuropathy in rodents treated with 1,2-DAB, (b) the neurochemical
basis for the neurotoxic properties of this compound, and (c) the structural
requirements for nerve fiber damage The properties of the neurotoxic compounds
1,2-DAB and 2,5-hexanedione (HID) are also compared. My hypothesis is that 1,2-
DAB affects axons by mechanisms similar to that of aliphatic y-diketone 2,5-HID,
and that this structural similarity provides the link between chromogenicity and
neurotoxicity.
ORGANIC SOLVENT NEUROTOXICITY
Organic solvents are used for extracting, dissolving, or suspending materials
such as fats, waxes, and resins that are not soluble in water. The National Institute
for Occupational Safety and Health (NIOSH) estimates that 9.8 million workers are
potentially exposed to organic solvents used in products such as paints, adhesives,2
glues, coatings, and degreasing/cleaning agents, as well as in the production of
dyes, polymers, plastics, textiles, printing inks, agricultural products, and
pharmaceuticals (NIOSH, 1987). Over 1.3 million civilian and military personnel
are occupationally exposed to hydrocarbon fuels such as gasoline, jet fuel, diesel
fuel, or kerosene (Ritchie et al., 2001). Since organic solvent (chemicals are
usually) are mixed together, it is difficult to distinguish the precise mechanism of
action of an individual agent. Moreover, it is unknown whether additive or
synergistic interactions may result in unpredicted neurotoxicity.
Organic solvents are broadly classified as aliphatic hydrocarbons,
halogenated hydrocarbons, and aromatic hydrocarbons. An aromatic compound is
an organic compound that contains one or more benzene or equivalent heterocyclic
rings. An aliphatic hydrocarbon is any nonaromatic hydrocarbon compound in
which the constituent carbon atoms form open chains. Some organic solvents are
known carcinogens (benzene, carbon tetrachioride, trichioroethylene, and 1,1,2,2-
tetrachloroethane); others are reproductive hazards (2-methoxyethanol, 2-
ethoxyethanol, and methyl chloride), or have neurotoxic properties (n-hexane,
xylene, and tetralin) (NIOSH, 1987).
ALIPHATIC HYDROCARBONS
Aliphatic hydrocarbons and their metabolites are known to pose threats to
human health. Motor and sensory neuropathy in induced in humans and animals by
repeated exposure to n-hexane, methyl n-butyl ketone (MBK), which acts via their
neurotoxic metabolite, 2,5-HD (Fig. 1.1).
One common aliphatic hydrocarbon solvent is n-hexane, once widely used in
industrial and commercial processes, including rubber, adhesive, ink, and paint
manufacturing, and in the extraction of vegetable oils for human consumption
(IPCS, 1991). The first case of peripheral neuropathy following prolonged3
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Figure 1.1. Biotransformation of n-hexane and MBK to 2,5-HD in mammalian
systems.
n-hexane exposure happened in poorly ventilated polyethylene laminating
operations (Takeuchi, 1993). Workers presented with an insidious progression of a
number of neuropathic signs and symptoms, including acral paresthesia, weakness
in the lower limbs, foot-drop, and moderately to severely compromised tendon
reflexes. These motor and sensory deficits are symmetrical and usually limited to
the feet and hands (Spencer and Schaumburg, 1977b).
The American Conference of Governmental Industrial Hygienists Threshold
Limit Value (TLV) for n-hexane in occupational exposure is 50 ppm(l8OmgIm3)inru
air, while the U.S. Occupational Safety and Health Administration Permissible
Exposure Limit (PEL) is SOOppm (DeCaprio, 2000).
Another aliphatic hydrocarbon, MBK, a neurotoxic metabolite of n-hexane,
is rarely used today in pure form. However, MBK is still present in some ketone-
based solvent mixtures. Additionally, it occurs as a by-product of wood pulping
and various petroleum processes; it is also a naturally occurring component of
certain foods (Arlien-Soborg, 1992). Human neuropathy due to occupational MBK
exposure was first encountered in 1973 at a facility that printed vinyl-coated fabric
in Ohio (Billmaier et al., 1974). Eighty-six workers out of 1157 tested subjects in
the plant were diagnosed with a toxic peripheral neuropathy. The TLV for MBK is
Sppm(20mg/rn3)in air, with a PEL of lOOppm. The U.S. National Institute for
Occupational Safety and Health has recommended lowering the TLV for MBK to
lppm (DeCaprio, 2000).
The neurotoxicity of n-hexane and its metabolites has been studied in a
number of animal species (Arlien-Soborg, 1992; IPCS, 1991: O'Donoghue, 1985;
Spencer et al., 1980b). Exposure to high levels of both n-hexane and MBK by
inhalation results in typical signs of solvent overexposure, including respiratory
depression, narcosis, convulsions, coma, and death (Spencer et al., 1980b). Lower
and subchronic exposure induces distal axonopathy in both CNS and PNS nerve
fibers. Exposure to a solvent mixture containing n-hexane resulted in neurological
dysfunction confined to a sensonmotor or motor peripheral neuropathy (Altenkirch
et al., 1982). Rats exposed to 1300 ppm MBK exhibited hindlimb foot drop after 3-
month exposure, while n-hexane-exposed animals displayed an unsteady gait after
6-week exposure, and bilateral hindlimb neuromuscular weakness and paralysis
thereafter (De Jesus et al., 1977; Okamoto et al., 1977).
2,5-HD, the y-diketone metabolite of the aliphatic solvents n-hexane and
MBK, is responsible for the induction of axonal degeneration. Rats or cats treated
with n-hexane or 2,5-HD revealed a characteristic pattern of scattered, focal
paranodal or internodal axonal swelling, a corresponding thinning of myelin, and
axonal degeneration in peripheral nerves. Electron microscopic studies5
demonstrated that the axonal swellings consisted of densely packed masses of
lOnm neurofilaments with segregation of other axonal organelles (mitochondria,
microtubules) into a discrete central zone (Spencer and Schaumburg, 1977a).
Neuropathological examination revealed that the most susceptible sites to
n-hexane, MBK, 2,5-HID within the CNS appeared to be the distal regions of large
myelinated fibers within the dorsal spinocerebellar, gracile, cuneate, ventrolateral,
and ventromedial tracts, while the tibial nerve branches to the calf muscle were
affected earliest in the PNS (Spencer and Schaumburg, 1977a,b).
Electrophysiological and behavioral deficits are present in experimental
animals exposed to n-hexane or its metabolite. Monkeys and rats exposed
chronically to lOOppm MBK (6hlday, 5 days/week, 10 months) exhibited reduced
nerve conduction velocity in sciatic-tibial nerves and decreased amplitude of
evoked muscle action potentials (Johnson et al., 1977).
AROMATIC HYDROCARBONS
Several widely used aromatic hydrocarbon solvents reportedly induce blue-
green discoloration of tissues and urine in animals (Table 1.1) and humans
(Gerarde, 1960; Spencer and Schaumburg, 1980).
Benzene is used extensively as a solvent in the chemical and drug
industries, as both a starting and intermediate material in the synthesis of numerous
chemicals, and as a constituent of motor fuels. High-level exposure causes CNS
depression; chronic, low-level exposure depresses the hematopoietic system and is
associated with leukemia (Schaumburg, 2000).
Toluene is used as a solvent for synthetic rubber, paint, and lacquers, as
well as a constituent of motor fuels. Chronic inhalation abuse of pure toluene
produces irreversible cerebellar, brainstem, and pyramidal-tract dysfunction (Boor
and Hurtig, 1977; Grabski, 1961; King et al., 1981; Lazar et al., 1983). Ototoxicity
is found in experimental animals exposed to toluene or xylene (McWilliams et al.,Table 1.1. List of aromatic hydrocarbons reported to produce blue-colored urine
MONOCYCLIC DICYCLIC
Benzene Indane
1 ,2-Xylene Indene
1 ,2-Ethyltoiuene Tetralin
1 ,2-Diethylbenzene Diphenyl
1 ,3-Diethylbenzene Diphenylmethane
1 ,2-Dii sopropylbenzene 1 -Methylnaphthalene
Triethylbenzene (mixture) 2-Methylnaphthalene
Diethyidiisopropylbenzene 1 -Ethylnaphthalene
2-Ethylnaphthaiene
Data generated from studies of albino rats treated with a single
subcutaneous injection of the listed substance (purity not stated) in a dose ofCa.5
mi/kg (Gerarde, 1959, 1960). With regard to the diethyibenzene isomers, treatment
of male and female rats and hamsters with 1,2-diethylbenzene (1,2-DEB) and 1,3-
diethylbenzene (1 ,3-DEB) caused the excretion of a blue dye in the urine. The
sciera, blood, plasma, and tissues were stained a deep blue that persisted for many
days. The rabbit did not excrete blue-colored urine but the sciera was stained blue
after administration of large doses of 1,2-DEB or 1,3-DEB. The guinea pig did not
excrete blue urinary metabolites with these agents.1 ,4-DEB was not chromogenic
in the rat, hamster, guinea pig, or rabbit (Gerarde, 1960). Later studies using
purified compounds found that 1,2-DEB (95%), but neither 1,3-DEB (99%) nor
1 ,4-DEB (96%), was chromogenic in Sprague-Dawley rats given repeated oral
doses of 500 and 750 mg/kgld, 5 days/week for 10 weeks (Gagnaire et al., 1990).
2000; Pryor and Rebert, 1984). Toluene is a teratogen in humans and experimental
animals. In rat studies, high levels of toluene impaired fetal growth and produced a
variety of fetal malformations (Pearson et al., 1994).
Tetralin (tetrahydronaphthalene) shows chromogenic and acute neurotoxic
properties in animals and humans. Babies, children, and adults are reported to have
developed acute neurological disturbances (headache, asthenia, restlessness, stupor)
in association with the excretion of green-colored urine after exposure to freshly
applied varnishes and waxes containing tetralin or derivatives thereof (Browning,
1965; Longacre, 1987). A woman excreted green-gray urine within approximately7
one day of ingesting approximately 250m1 of an ectoparasiticide containing 31.5%
tetralin (Drayer and Reidenburg, 1979). Tetralin produced hindlimb weakness in
guinea pigs treated orally, percutaneously or by inhalation (Smyth et al., 1951).
Musk tetralin (8-acetyl-7-ethyl- 1,1 ,4,4-tetramethyl- 1 ,2,3,4-tetralin), a white
compound once used worldwide in fragrances and as a food additive, also causes
blue discoloration of tissue (including the brain), green-colored urine, hyperactivity
followed by hindlimb weakness, a progressive neuronal ceroid degeneration, and
[I:
AETT Keto AETT
LiJ
Figure. 1.2. Formula of acetyl ethyl tetramethyl tetralin (AEY1F) and keto-AETT,
the chromogenic putative metabolite of AETT
central and peripheral neurodegeneration (Spencer et al., 1979a). Since methyl
substitution of the 7-ethyl group blocked the chromogenic and neurotoxic
properties, AETT-induced neurotoxicity may be linked to chromogenicity
(Spencer, 1982). The metabolite of AETI ("keto AETT") is a chromogenic
compound that forms a blue color on contact with amino acids, peptides and
proteins.
This observation raised the possibility that other chromogenic aromatic
hydrocarbons, such as 1 ,2-DEB, may have neurotoxic properties comparable to
those of musk tetralin (http://www.ohsu.edu/croet/peterbook/pdf/Ch.20.pdf,
Spencer et al., 1980a).The two compounds addressed in the present are diethylbenzene (DEB) and
diacetylbenzene (DAB). DEB is a minor component of aromatic solvents that are
widely used in industry and serves as an intermediate for the production of
divinylbenzene (Sandmeyer, 1981). It is a colorless, flammable liquid that exists as
three isomers: 1,2-(ortho), 1,3-(meta), and 1,4-(para)-DEB. 1,2-DAB is a putative
neurotoxic metabolite of 1,2-DEB. By intrapentoneal injection, 1,2-DAB is
several-fold more toxic (body weight change) and neurotoxic (peripheral
neuropathy) than 1,2-DEB (Gagnaire et al., 1991, 1992a).
[II
1 ,2-Diethylbenzene 1 ,2-Diacetylbenzene
Figure. 1.3. Formula of 1,2-diethylbenzene (DEB) and 1,2-diacetylbenzene,
the chromogenic putative metabolite of 1,2-DEB.
Rats treated with 1 ,2-DEB or 1,2-DAB excrete blue-green urine and
develop electrophysiological changes consistent with peripheral neuropathy. By
contrast, neither 1 ,3-DEB nor 1 ,4-DEB are chromogenic or neurotoxic (Gagnaire et
al., 1990). The chromogenic and neurotoxic properties of 1,2-DEB appear to arise
from the proposed active metabolite 1,2-DAB (Gagnaire et al., 1991; Payan et al.,
1999). In addition, rats treated with 1,2,4-triethylbenzene, but not 1,3,5-
triethylbenzene, showed bluish skin with greyish-green urine and decreased motor
and sensory conduction velocities. Taken together, these data suggest that two ethyl
residues in the ortho position on an aromatic ring (y-diketone structure) are requiredfor chromogenicity and neurotoxicity (Gagnaire et al., 1993). While 1,2-DEB and
1,2,4-triethylbenzene cause electrophysiological changes consistent with
sensorimotor neuropathy in rodents, but underlying mechanisms and pathogenesis
are unclear.
Chromogenicity may thus be a clue to neurotoxicity. Widely used
neurotoxic aromatic hydrocarbon solvents (tetraline or tetralin derivatives)
reportedly induce blue-green discoloration of tissue and urine in animals and
humans. Several reports document the relationship between human exposure to
aromatic solvents and the excretion of green-colored urine (Pohi and Rawicz, 1919;
Rockemann, 1922; Koelsch, 1926; Lehman and Flury, 1943; Badinand et al., 1947;
Browning, 1953; Drayer and Reidenberg, 1979; Grant et al., 1985; Longacre,
1987). The chromophore has been proposed to result from a ninhydrin-like reaction
with amino groups in proteins (Spencer et al., 1980a). Systemic treatment of
rodents with 2,5-HD results in an orange-reddish discoloration of hair that contains
pyrrole substituents (Johnson et al., 1995).
PERIPHERAL NEUROPATHY
Peripheral neuropathy is a disorder of nerves associated with inflammation,
decreased blood flow, trauma or exposure to toxic substances (e.g. 2,5-HID or 1,2-
DAB). Degeneration of the axon blocks conduction at the point of the
degeneration. Demyelination (loss of the myelin sheath that surrounds the axon)
greatly decreases the speed of impulse conduction along the nerve.
Damage to sensory nerve fibers results in changes in sensation ranging from
pain, decreased sensation, lack of sensation, perception of abnormal sensations, or
an inability to determine joint position sense in the area. Sensation changes usually
begin in the feet or hands and progress toward the center of the body.
Damage to motor nerve fibers causes muscle weakness, lack of muscle
control, difficulty or inability to move a part of the body (paralysis), loss of muscle10
function or feeling, muscle atrophy, and muscle twitching (fasciculation)(Kandel et
al., 2000).
After prolonged exposure to relatively high levels of certain aliphatic
solvents (e.g. n-hexane, MBK), humans and animals develop a dose-dependent
distal, retrograde degeneration of long and large axons in the peripheral nerve and
spinal cord (central-peripheral distal axonopathy). Neurological symptoms initially
develop in the extremities (Spencer and Schaumburg, 1975; DeCaprio, 2000).
Rats treated with 1 ,2-DEB or 1,2-DAB developed blue discoloration of
tissue followed by the appearance of electrophysiological deficits (decreased motor
and sensory conduction velocities of peripheral nerve fibers in the rat tail) and
altered brainstem auditory evoked potentials (Gagnaire et al., 1990, 1991, 1992a,b).
AXONOPATHY
The neuron is the functional unit of the nervous system. It consists of three
parts: the cell body, called the soma, and the dendrites and axon. Cytoskeleton
proteins in the axon such as microtubules, neurofilaments (NFs), and
microfilaments, are responsible for structural integrity and axonal transport. They
move anterograde from their site of synthesis in the nerve cell body along the axon
to the nerve terminal. Microtubules are 25-28nm in diameter and composed of a-
and-tubulin. NFs are 10 nm in diameter and consist of NP triplet protein NF-H,
M, -L subunits. NP has been proposed as a critical target for a number of agents
that induce axonopathy (Graham et al., 1982). Microfilaments, the smallest
elements, are 3-5 nm in diameter, and polar polymers of globular actinmonomers
are wound into a double-stranded helix. The microtubule-associated proteins
(MAPs), including tau, form cross bridges between microtubules and other
cytoskeletal constituents, as well as cellular organdies (Kandel et al., 2000). While
the precise targets of axonal neurotoxins are unknown, plausible candidates also
include proteins responsible for maintaining the supramolecular organization of the11
cytoskeleton (Monaco et al., 1990), such as plakins; proteins responsible for
phosphorylation/dephosphorylation of NF subunits; and the motor proteins kinesin
and dynein (Stone et al., 1999).
"Axonopathy" refers to primary degeneration of the axon, such as occurs in
2,5-BID axonopathy. The protein targets of toxic attack in neurofilamentous and
other axonopathies have yet to be identified. In this study, it was important to
determine first whether neuropathological changes in spinal cord and spinal roots
were correlated with the onset of limb weakness in rats treated with DAB isomers.
Rats treated with 1,2-DAB, but not 1,3-DAB, developed limb weakness associated
with proximal neurofilament (NF)-filled giant axonal swellings comparable to
those seen in animals treated with the 3,4-dimethyl- 2,5-RD (DMHD) (Kim et al.,
2001).
Several neurotoxic chemicals such as acrylamide, carbon disulfide (CS2),
j3'-iminopropionitri1e (IDPN), 2,5-BID, neurotoxic y-diketone metabolite of n-
hexane, or MEK produce axonal swelling filled with 10 nm NFs (Couri and Milks,
1982; Gottfried et al., 1985). These chemicals disrupt microtubule-NF relationships
and cause accumulations of NFs in proximal (IDPN) or distal (2,5-HD andCS2)
regions of affected axons (Spencer and Schaumburg, 1975; Tashiro et al., 1994;
Stone et al., 1999). Although proteins of all tissues are derivatized and cross-linked
after exposure to CS2, the toxicologically relevant reactions are those that occur
with long-lived proteins, such as the subunits of the neurofilament (Graham et al.,
1995).
MECHANISMS OF AROMATIC AND ALIPHATIC y-DIKETONE
AXONOPATHY
Chemicals that cause toxic axonopathy target systems within the axon on
which the nerve fiber depends for maintenance of structural and functional
integrity. A prominent feature of neurofilamentous axonopathies is the segregation12
of microtubules that penetrate amassed NFs in giant axonal swellings. This is seen
in the peripheral nerves of rats systemically treated with 2,5-HID or IDPN and can
also be reproduced by local application or intraneural injection of high
concentrations of either agent to intact sciatic nerves in living animals (Zagoren et
al., 1983; Griffin Ct al., 1983). We have observed (Kim et al., 2001) a similar
phenomenon after systemic treatment of rats with 1,2-DAB (10-20 mg/g/d i.p.).
Western blot analysis of intrafascicular nerve tissue showed that NE-M was more
sensitive than 13-tubulin to 1,2-DAB-induced cross-linking. Similarly, in spinal
cord in vitro, NE-H and NF-M were more sensitive than 3-tubulin to 1,2-DAB. In
vitro studies using a native rat NE model system comparably demonstrated that 2,5-
HD affects NE-H and NF-M more than NF-L (DeCaprio and Fowke, 1992). Mice
heterozygous or homozygous for the NF-H null mutation fail to develop
neurofilamentous swellings and segregated microtubules in motor neurons after
systemic IDPN treatment. These results indicate that the NE-H subunit is a key
mediator of IDPN-induced axonopathy (Zhu et al., 1998).
The y-diketone structure underlies the neurotoxic property of the aliphatic
hydrocarbon 2,5-HD and DMIHID neurotoxicity. Of a senes of diketones tested for
neurotoxicity in rats, only y-diketones, including 2,5-HID, 2,5-heptanedione, and
3,6-octanedione, were found to induce the classic clinical signs and pathological
changes associated with n-hexane neuropathy (Spencer et al., 1978). In contrast, a-
diketones (2,3-butanedione, 2,3 -hexanedione), f3-diketones (2,4-hexanedione, 2,4-
pentanedione, and 3,5-heptadione), and an E-diketone (2,7-octanedione) were not
neurotoxic.
The y-diketone neurotoxic agents 2,5-HD and DMIHD form pyrrole adducts
with axonal and other proteins, particularly NF protein (DeCaprio et al., 1982).
Subsequent autooxidation causes cross-linking of NE and development of axonal
neuropathy (Anthony et al., 1983a). Heavier molecular weight subunits represent
diketone-NF pyrrole adducts that have presumably undergone secondary covalent
intermolecular NF-NF cross-linking (Graham et al., 1982). Pyrrole adduct13
formation decreased NF solubility within the axoplasm, resulting from formation of
hydrophobic pyrrole adducts, which might alter their transport or metabolism
(DeCapno et al., 1983). Progressive proximodistal NF cross-linking is proposed to
impair anterograde NF translocation across narrow nodes of Ranvier and thereby
promotes accumulation of derivatized NFs with subsequent axon swelling and
degeneration.
During treatment with an aliphatic y-diketone, the extent of longitudinal
movement and position of arrest of NF proteins are associated with the protein
reactivity and neurotoxic potency of the selected agent. Compared with
2,5-HD, which develops distal giant axonal swellings after chronic treatment,
3-methyl-2,5-hexandione and DMHD cause NF transport arrest at mid-level and
proximal locations, respectively (Monaco et al., 1990; Anthony et al., 1983). On
the basis of a comparison of the position of arrest of NF proteins, I ,2-DAB thus
might have neurotoxic potency similar to that of DMIHID.
NF is unlikely to be the crucial lesion, however, because wild-type mice
that express NF proteins and transgenic mice that do not, both display similar
patterns of distal axonal degeneration in 2,5-FID neuropathy (Stone Ct al., 2001).
Other potential targets of y-diketones are microtubules, motor proteins such as
kinesin or dynein, microtubules, microtubule-associated proteins, and enzymes
involved in supplying energy for the transport of materials along the axon (Spencer
et al., 1980b; Graham, 1999).
HYPOTHESIS AND MEDICAL SIGNIFICANCE
The studies presented in this dissertation examine the hypothesis that the
mechanism of 1,2-DAB axonopathy is similar to that of aliphatic y-diketone 2,5-
HD. To test this hypothesis, the following specific studies were conducted:
1.Examine morphological changes induced by DAB isomers using light
and electron microscopy (Chapter 2).14
2.Examine reactivity of DAB isomers with amino acids and proteins.
Determine protein adduct formation with 1,2-DAB or 2,5-HD and
purified proteins, and enzymesin vitro,and proteins present in spinal
cord and sciatic nerves treatedin vitroandin vivo(Chapter 3).
My studies lead to conclusion that the structure relationship (y-diketone) and
neurotoxic effects (neurofilamentous axonopathy) of 1,2-DAB and 2,5-kID are
shared. Aromatic hydrocarbon 1,2-DAB, compared with 2,5-I-ID, induced proximal
neurofilamentous axonopathy and showed high protein reactivity.
My findings may shed light on medical problems beyond the scope of
neurotoxicity. 1,2-DAB-induced proximal axonal swellings filled with lOnm-NFs
are the pathological hallmark of amyotropic lateral sclerosis (ALS). Lewy bodies
that contain NF protein are pathological determinants of Parkinson's disease
(Hughes et al., 2001). Whether the NF proteins are the cause or consequence of the
diseased state remains to be clarified. Recent evidence suggests the involvement of
Cu, Zn superoxide dismutase, which leads to accumulation of NF aggregates (Price
et al., 1997). Additionally, a recombinant mouse strain that overexpresses NP-H
shows abnormal NF accumulations resembling those found in ALS (Julien et al.,
1998).
1,2-DAB has been shown to crosslink and polymerize NFs and arrest their
movement along the axon. This may explain the appearance of swellings filled with
NF in proximal axons. Further studies are required to illuminate the mechanism of
NF accumulation and formation of axonal swellings in 1,2-DAB-treated animal.15
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ABSTRACT
1 ,2-Diacetylbenzene, the Neurotoxic Metabolite of a Chromogenic Aromatic
Organic Solvent, Induces Proximal Axonopathy. Kim, M-S, Sabri, M.I., Miller,
V.H., Kayton, R.J., Dixon, D.A., and Spencer, P.S. (2001) Toxicol. Appi.
Pharinacol. 177,121-131.
Several widely used aromatic hydrocarbon solvents reportedly induce blue-
green discoloration of tissues and urine in animals and humans. The chomophore
has been proposed to result from a ninhydrin-like reaction with amino groups in
proteins. The present study examines the neurotoxic property of 1,2-
diacetylbenzene (1,2-DAB), the active metabolite of the chromogenic and
neurotoxic aromatic solvent 1,2-diethylbenzene. Rats treated with 1,2-DAB, but not
with the non-chromogenic isomer,1,3-DAB, or with ninhydrin, developed blue
discoloration of internal organs, including the brain and spinal cord. Only 1,2-
DAB induced limb weakness associated with nerve fiber changes, which were most
prominent in spinal cord and spinal roots. Changes began with the formation of
proximal, neurofilament-filled axonal swellings of the type seen after treatment
with 3,4-dimethyl-2,5-hexanedione, a potent derivative of the active metabolite of
the neurotoxic aliphatic hydrocarbon solvents n-hexane and methyl n-butyl ketone.
These compounds are metabolized to a y-diketone that forms pyrroles with target
proteins, such as neurofilament proteins. A comparable mechanism is considered
for 1,2-DAB, an aromatic y-diketone.
Key Words: Diethylbenzene, diacetylbenzene, aromatic solvent, ninhydrin,
tetralin, chromophore, neuropathy, axonopathy, green urine.17
INTRODUCTION
More than 80 years have elapsed since the first report of a relationship
between human exposure to aromatic solvents (tetralin or tetralin derivatives) with
acute neurotoxic properties and the excretion of green-colored urine (Pohl and
Rawicz, 1919; Rockemann, 1922; Koelsch, 1926; Lehmann and Flury, 1943;
Badinand et al., 1947; Browning, 1953; Drayer and Reidenberg, 1979; Grant et al.,
1985; Longacre 1987). Over 40 years have passed since green-colored urine was
reported in rats treated with a single subcutaneous dose of tetralin, one of a list of
reportedly chromogenic aromatic hydrocarbon solvents that includes 1,2-
diethylbenzene (1,2-DEB) (Gerarde, 1960, see also Spencer, 2000a,b and Spencer
et al., 2001). Over 20 years ago, the chromogenic property of a tetralin derivative
(AETT: 1,1 ,4,4-tetramethyl-6-ethyl-7-acetyl- 1,2,3 ,4-tetrahydronaphthalene),
formerly used worldwide in fragrances and as a food additive, was linked to
pathological changes in neurons and myelin in the central and peripheral nervous
system of rats treated with repeated dermal or oral applications (Spencer et al.,
1979a,b; Spencer et al., 1980a). This observation raised the possibility that other
chromogenic aromatic hydrocarbons, such as 1,2-DEB, may have comparable
neurotoxic properties (Spencer and Schaumburge, 1985).
The first report linking the chromogenic and neurotoxic properties of
1,2-DEB appeared over 10 years ago (Gagnaire et al., 1990). Rats treated orally or
by inhalation with 1 ,2-DEB or its putative metabolite, 1 ,2-diacetylbenzene (1,2-
DAB), developed blue discoloration of tissue followed by the appearance of
electrophysiological deficits consistent with sensorimotor neuropathy and altered
brainstem auditory evoked potentials (Gagnaire et al., 1990, 1991,1992a,b). By
contrast, the investigators were unable to produce peripheral nerve conduction
changes in rats treated orally with either of the non-chromogenic isomers 1,3-
diethylbenzene (1,3-DEB) or 1,4-diethylbenzene (1,4-DEB) (Gagnaire et al., 1990).
1 ,2,4-Triethylbenzene but not 1 ,3,5-triethylbenzene showed comparable
chromogenic and neurotoxic properties, suggesting that the presence of two ethylLL
residues in the ortho position on an aromatic ring is required for chromogenicity
and neurotoxicity (Gagnaire et al., 1993).
The chromogenic and neurotoxic properties of 1 ,2-DEB seem to arise from
the proposed active metabolite 1,2-DAB (Gagnaire et at., 1991; Payan et at., 1999),
which reacts with amino acids to form colored pigments (Nan'ya and Maekawa,
1977a; Bayle-Lacoste et al., 1987; M-S Kim et al., 2000b). In contrast to 1,2-
DEB, the urinary metabolite 1,2-DAB produces a blue color on contact with human
and animal skin (Nan'ya and Maekawa, 1977b; Kim et al., 2000b). By the
intraperitoneal route, 1,2-DAB is severalfold more toxic (body weight) and
neurotoxic (peripheral neuropathy) than 1,2-DEB (Gagnaire et al., 1991, 1992a).
Our preliminary work shows that the structure-activity requirement for
chromogenicity and neurotoxicity reported for DEB isomers also holds for DAB
isomers (Kim et al., 1999, 2000a). The present study employs light and electron
microscopy to confirm the structure-activity requirements for DAB neurotoxicity
and to define the neuropathologic process induced by 1,2-DAB. The effects of
DAB isomers (1,2-DAB, 1,3-DAB) are compared with those of ninhydrin (2,2-
dihydoxy-1,3-indanedione), a compound that reacts with amino acids to form a
blue pigment (Ruhemann's purple). The Ruhemann reaction has been postulated to
be involved in the genesis of the chromogenicity associated with the diketo
derivative of AETT (1,2-diacetyltetramethyltetralin) and 1,2-DAB (Spencer et aL,
1980a; Zhan et al., 2001).MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats weighing 175-225 g on arrival were used.
Animals were acclimated individually in home cages for 5 days prior to treatment.
Cages were supplied with soft, absorbent bedding, and animals were given Purina
rat chow and water ad libitum. Stacked cages were held in a quiet room provided
with a 12h/12h light-dark cycle and held at a temperature of 20°C. Animals were
randomly selected for treatment with test articles.
Chemicals
1,2-DAB (99%), 1,3-DAB (97%) and ninhydnn (97%) were purchased
from Aldrich Chemical Co. (Madison, WI) and dessicated at room temperature
(1,2-DAB) or stored at 4°C (1,3-DAB). Purity of all test agents was checked bygas
chromatography-mass spectrometry (GC-MS). Each substance was dissolved in 2%
HPLC-grade acetone, 0.9% saline added, the solution shaken and (for 1,3-DAB)
warmed to achieve maximum solubilization of the test article in target
concentrations of approximately 0.06 M or 0.12 M. DAB isomers and ninhydnn
were stable when this solution was stored at room temperature for 7 days. All other
chemicals were of analytical grade.20
Animal treatment
Rats were weighed daily (scoping study), every other day (preliminary
study) or twice weekly (formal study) to track body weight changes and adjust the
dosage of the test article. Animals were treated in the morning and their behavior
and locomotion in an open field examined qualitatively in the afternoon. Video-
recordings were made of selected animals in a highly illuminated open-field
setting.
Test articles were administered intraperitoneally with a 1-mi disposable
plastic syringe equipped with a 27-guage needle. Injection sites were rotated
around the abdomen. Care was taken to minimize leakage. N-Butyl
benzenesulfonamide, a neurotoxic substance found in some types of plastic syringe
(Strong et al., 1991), was not detected by GC-MS in test articles held for up to 1
day in syringes identical to those used for injection. At termination of treatment,
rats were individually anesthetized with 3% isofluorane in oxygen, the chest
opened and the animal injected intracardially with 200tl of heparin (1000 units/mi)
solution. Immediately thereafter, the animals were perfused through the ascending
aorta with 4% paraformaldehyde (10 sec) followed by 5% glutaraldehyde (1 liter),
each in ice-chilled phosphate buffer (pH 7.4).
Tissues were sampled from the central nervous system (CNS), including
brain (frontal cortex, midbrain, cerebellum and optic tract), medulla oblongata and
lumbar spinal cord. Peripheral nervous system (PNS) tissues included lumbar
dorsal and ventral spinal roots, lumbar dorsal root ganglia, sciatic nerve (proximal
and distal), tibial nerve branches to the calf muscles, and tibia! nerve at the ankle.
All tissues were post-fixed with 1% osmium tetroxide in phosphate buffer,
dehydrated, and embedded in epoxy resin. One-micrometer-thick tissue sections of
all regions were stained with 1% toluidine blue and screened by bright-field
microscopy. Thin sections of areas of special interest were stained with 2% uranyl
acetate followed by 1% lead citrate and examined by transmission electron
microscopy.21
Dosing regimens
Scoping studies were carried out to estimate the neurotoxic dosage of
1,2-DAB. Animals were given 9 injections of saline (n=4) or 20 mg/kg/day 1,2-
DAB in saline (n=4) administered over 2 weeks. Nine days after treatment began,
there was severe weight loss accompanied by tissue and urine discoloration.
Changes in neuro-behavioral status were evident in the form of post-injection
hyperactivity, aggressive behavior, back-arching and limb weakness. The dosage
of test articles was therefore halved in preliminary studies to compare the effects of
1,2-DAB, 1,3-DAB and ninhydrin. Animals were treated for 30 days either with
saline (n=4) or with 10 mg/kg/d 5 days/week of each agent in saline (n=4 per
group) for a total dose of 220 mg/kg/animal.
Formal studies were carried out to assess the spatial-temporal evolution of
neuropathological changes induced by 1,2-DAB. For this purpose, animals were
treated in the manner described above with saline for 3 weeks (n=4), 6 weeks (n=4)
or 9 weeks (n=4) or saline containing 10 mg/kg/day 1,2-DAB 5 days/week for 3
weeks (total dose: 150 mg/kg, n=4), 6 weeks (300 mg/kg, n=4) or 9 weeks (450
mg/kg, n=4). Daily visual examination was used to monitor general health, skin
color, hair texture, posture, and locomotion. Body weights were examined twice
weekly and the results used to adjust the dosage of the test article. Animals were
randomly selected at each timepoint for neuropathological study.RESULTS
Animal observations
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DAB Treatment. Changes in body weight were related to the daily dosage
of 1,2-DAB. Whereas all animals in the scoping study lost body weight (mean,
25%; 20 mglkg/d for 9 days), all animals gained body weight erratically in the
preliminary study (mean, + 18%; 10 mg/kg/d for 30 days). Body weight gain in all
1,3-DAB-treated rats (mean, +36%; 10 mg/kg/d for 30 days) was steady and
comparable to that in animals treated with saline (mean, +38% in 30 days) in the
preliminary study. Whereas all animals treated with saline in the formal study
steadily gained body weight, rats treated with 1,2-DAB steadily but more slowly
gained body weight for 39 days and lost body weight between day 39 and day 60 of
treatment. There were no animal losses. There was a marked difference between the
physical appearance of animals treated with 1,2-DAB versus 1,3-DAB, ninhydrin
or saline. In the scoping, preliminary and formal studies, all animals treated with
1,2-DAB rapidly developed darkened eyes and a bluish tone to the exposed skin
(ears, paws, tail) (Fig. 2.1).' 4\I -
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Figure 2.1.Rats treated with 10 mglkg/d for 25 days with 1,2-DAB (A) or
saline (B). Note the discoloration of the ears, paws and tail with 1,2-
DAB treatment.
These animals also developed a reactive bladder and greenish urine,
circumoral porphyrin deposition, and late epistaxis. In the absence of aldehyde
perfusion, blue discoloration was present throughout body organs and tissues of all
1,2-DAB-treated animals, especially the kidneys and testes, and including the
brain, spinal cord and peripheral nerves, and plasma. Skin at injection sites was
also densely stained blue. After aldehyde perfusion, the brains of 1,2-DAB-treated
animals were discolored relative to the amber coloration of brains removed from
animals treated with 1,3-DAB or saline (Fig. 2.2). Intestinal bloating and brittle
bones were also noted in 1,2-DAB-treated rats.24
Figure 2.2.Brains of rats treated for 30 days with saline (A), 1,3-DAB (B),or
1,2-DAB (C) (10 mg/kgld 5 days/week treatment with either DAB
isomer).
Most animals treated with 20 mg/kg/d 1,2-DAB showed post-injection and
touch-induced hyperactivity, drowsiness, and aggressiveness (including biting)
toward the handler. Thereafter, the animals weakened, developed an arched back,
distal forelimb weakness, and then hindlimb paresis. Rats treated with 10 mglkg/d
5 days/week for 30 days showed no clear-cut neurological signs. In the formal
study, rats typically showed distal forelimb weakness at 6 weeks, and hindlimb and
forelimb splaying at 9 weeks. All animals maintained their ability to eat and drink
throughout the course of the experiment.
Ninhydrin Treatment. Three of four animals treated with ninhydrin initially
lost body weight, and one animal died after 7 days of progressive body weight loss.
All remaining animals subsequently gained body weight (mean of +23% at 30
days). No behavioral or pathological signs of neurodegeneration were evident in25
any animal after 30 days of treatment with ninhydrin. These animals showed at the
injection site a tendency to hemorrhage (20 days) and a blue discoloration of skin
(1 day), but no discoloration of brain, spinal cord, skin, eyes or abdominal organs
was seen. At autopsy, the liver was generally speckled and reduced in size, and
intestinal bloating and obstruction were evident.
Taken together, these results showed that 1,2-DAB, but neither 1,3-DAB
nor ninhydrin, induced blue nervous tissue discoloration associated with the
development of progressive limb weakness.
Neuropathology
The quality of tissue fixation was generally of high standard in all regions
of the CNS and PNS examined. Focus was placed on the lumbar spinal cord and
spinal roots, the site of the earliest and most dramatic nerve fiber changes induced
by 1,2-DAB. No such changes were observed in animals treated with 1,3-DAB,
saline or ninhydrin.
Scoping Study. All rats developed hind limb weakness and corresponding
pathological changes in lumbar motor neurons. Intraspinal motor axons were
grossly enlarged and thinly myelinated, a pattern of neuropathology that has been
termed giant axonal swelling (Fig. 2.3A). Cross sections of axonal swellings
revealed densely packed neurofilaments and islands of clustered microtubules,
mitochondria, and vesicles (Fig. 2.3B). The soma of spinal neurons occasionally
contained abnormal lucent regions (Fig. 2.3C) that corresponded to skeins of
neurofilaments running between islands of rough endoplasmic reticulum (Fig.
2.3D). Evidence of abnormal somal lipopigmentation or neuronal degeneration was
not found.1
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Figure 2.3. Cross sections of lumbar spinal cord (A,C,D) and adjacent ventral
spinal root (B). (A) Anterior horn showing several motor neurons and a grossly
enlarged intraspinal axon (a). (B) Axoplasm containing aggregations (arrows) of
neurotubules, mitochondria and vesicles, surrounded by densely packed
neurofilaments. (C) A distended spinal neuron containing aggregated organelles
and abnormal lucent regions of cytoplasm (c). (D) Anterior horn cell cytoplasm
containing abnormal skeins of neurofilaments (n) and islands of ribosome-studded
endoplasmic reticulum. Light (A,C) and transmission electron (B,D) micrographs
of epoxy-embedded tissue of animals treated with 20 mg/kg/d 1,2-DAB for 2
weeks (9 individual daily injections). Bars represent 38 im (A), 0.9 p.m (B), 38 p.m
(C) and 2.3 p.m (D).
Preliminary Study. Neuropathological changes in these animals were
generally less advanced than those found in the scoping study. Scattered
intraspinal nerve fibers with giant axonal swelling were visible in the lumbar spinal
cord of all animals treated with 1,2-DAB (Fig. 2.4A) but not in corresponding
tissues of animals treated with 1,3-DAB (Fig. 2.4B), ninhydrin (Fig. 2.4C), or
saline (Fig. 2.4D).27
Figure 2.4. Cross sections of lumbar spinal cord. (A) Scattered giant swollen axons
(a) adjacent to an anterior horn cell containing abnormally lucent regions of
cytoplasm (arrows). Animal treated with 10 mg/kg/d 1,2-DAB 5 days/week for 30
days. (B, C) No abnormalities are visible after comparable treatment with 1,3-
DAB (B) or ninhydrin (C). (D) Normal tissue from animal treated for a similar
period with saline. Light micrographs of epoxy-embedded tissue. Bars represent 3
p.m (A), 40 p.m (B), 40 p.m (C) and 32 p.m (D).
Formal Study. CNS and PNS tissues were examined in rats treated for 3
weeks (no apparent limb weakness), 6 weeks (distal forelimb weakness) and 9
weeks (fore- and hindlimb weakness) of 1,2-DAB treatment.
At 3 weeks, intraspinal regions of lumbar motor axons showed a moderate
degree of axonal swelling and normal myelination, comparable in degree to that
seen in equivalent regions of animals in the preliminary study. Occasional swollen
myelinated fibers were seen in cross sections of lumbar dorsal root ganglia. Othersampled regions of the CNS (medulla oblongata, cerebellum, frontal cortex) and
PNS (sciatic nerve, tibial nerve) were within normal limits.
At 6 weeks, the anterior horn of lumbar spinal cord contained massively
swollen axons which, on rare occasion, could be seen in continuity with the soma
of an anterior horn cell of relatively normal appearance (Fig. 2.5A). Some motor
neurons contained zones of clear cytoplasm. Both these somal zones and their
associated swollen motor axons contained dense skeins of 10 nm neurofilaments
(Fig. 2.5B), together with aggregations of axonal organelles (mitochondria, dense
bodies).
Figure 2.5. (A) Light micrograph showing a massive focal swelling of the
proximal axon segment (a) of a lumbar anterior horn cell (n). (B) Transmission
electron micrograph of a thinly myelinated intraspinal motor axon filled with
neurofilaments. Tissue from rats treated with 10 mg/kg/day 1,2-DAB 5 days/week
for 6 weeks. Bars represent 52 tm (A) and 14.5 tm (B).29
In contrast to the lumbar ventral root of animals treated with saline (Fig.
2.6A) or 1,2-DAB for 3 weeks (Fig. 2.6B), pronounced giant axonal swelling was
evident in corresponding regions of animals treated for 6 weeks (Fig. 2.6C).
Several nerve fibers showed myelin splitting, with the formation of myelin bubbles.
Sciatic nerves, including large-diameter myelinated nerve fibers supplying the calf
muscles, showed no qualitative evidence of neuropathology.
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Figure 2.6. Light micrographs of cross sections of lumbar spinal cord and adjacent
ventral spinal root. (A) Saline treatment. Spinal cord (upper) and spinal roots
(lower) are normal in appearance. (B) 1,2-DAB (10 mg/kg/d, 5 days/week) for 3
weeks. Enlarged axons of some intraspinal myelinated nerve fiber pathways are
apparent. (C) Same 1,2-DAB dosage for 6 weeks. Giant axonal swelling and
myelin edema (e) are evident. (D) Same 1,2-DAB dosage for 9 weeks. Peripheral
nerve fibers display myelin bubbles (b). Bars represent 38 tm (A), 40 tm (B), 38
Jtm (C) and 38 p.m (D).30
At 9 weeks, spinal roots frequently displayed demyelination and myelin
bubble formation (Fig. 2.6D). By contrast, relative to the normal structure of cross-
sections of tibial nerve branches to the calf muscles of saline-treated rats (Fig.
2.7A), equivalent regions of 1,2-DAB-treated animals occasionally showed myelin
bubbles, some possibly shrunken myelinated fibers, and rare remyelinating and
degenerating fibers (Fig. 2.7B,C). Electron micrographs ofmyelin bubbles
disclosed an intact, attenuated axon surrounded by an intramyelinic edematous
space containing myelin debris (Fig. 2.8A) or phagocytes with ingested myelin
debris (Fig. 2.8B).
Figure 2.7. Light micrographs of cross sections of tibial nerve branches to the calf
musculature. (A) Saline treatment. (B, C) 1,2-DAB treatment (9 weeks). Note the
presence of a few scattered myelin bubbles (b) among the large majority of normal-
appearing and crenated myelinated fibers. One remyelinated fiber (r) is present.
Bars represent 30 .tm.
Comparable but less advanced pathological changes were seen elsewhere in
sampled CNS and PNS tissues of rats treated for 6 weeks (less change) or 9 weeks
(more change). As in the lumbar spinal cord and corresponding spinal roots,
myelinated fibers of large diameter were most obviously affected in vulnerable31
regions of the CNS. Giant axonal swellings were scattered throughout large-
diameter fibers in the white matter of the lumbar spinal cord. Spinal gray matter at
9 weeks contained intact anterior horn cells, slight evidence of astrocytosis, and
fewer swollen axons than at 6 weeks. In the medulla oblongata, the gracile and
cuneate fasciculi/nuclei were spared, but nerve fiber tracts running immediately
lateral to intact myelinated fibers in the pyramidal decussation showed progressive
Figure 2.8. Electron micrographs of cross sections of lumbar dorsal roots of rats
treated with 10 mglkg/d 1,2-DAB 5 days/week for 6 weeks. (A) Myelin bubble
with shrunken axon (a) associated with an edematous intramyelinic space (e)
containing myelin debris. (B). Myelin bubble containing a centrally locatedaxon
(a) associated with intramyelinic phagocytes (p) containing myelin debris. Bars
represent 4.6 jtm (A) and 9.2 p.m (B).
abnormalities at the two time points. Scattered giant axonal swelling butno marked
lipopigmentation was found in the hypoglossal nucleus. Comparable nerve fiber
pathology was evident in the region of the dentate nucleus, but no abnormalities
were found in the cerebellar vermis. No convincing changes were seen in motor
neurons or axons of the frontal cortex. Giant axonal swelling, demyelination and
myelin bubbles were not seen in optic nerves adjacent to the optic chiasm.32
DISCUSSION
The present study shows that DAB chromogenicity and neuronal toxicity
are properties restricted to the ortho isomer, 1,2-DAB. Since 1,3-DAB lacks these
properties, the presence (ortho) or absence (meta) of chromogenicity and
neurotoxicity among DAB isomers explains the comparable properties of the
corresponding isomers of the aromatic solvent diethylbenzene (DEB) (Gagnaire et
al., 1990). Taken together, this provides the first concrete evidence that aromatic
hydrocarbon solvents, like as their aliphatic hydrocarbon cousins (i.e., n-hexane
and methyl n-butyl ketone), show structure-dependent axonal neurotoxicity arising
from the likely generation of a neurotoxic y-diketone metabolite (discussed below).
In both cases, repeated systemic administration induces characteristic pathological
changes (giant axonal degeneration) in the CNS and PNS. Additional studies are
needed to determine whether pathological changes also develop in other organs.
Noteworthy in this regard is the induction of Sertoli cell degeneration in the testes
of animals treated with the aliphatic y-diketone, 2,5-hexanedione (Boekeiheide et
al., 2000).
The existence of a relationship between the chromogenicity and neuronal
toxicity of both DAB and DEB suggests the need to evaluate for neurotoxic
properties other reportedly chromogenic aromatic hydrocarbons, notably tetralin
(Gerarde, 1960). Tetralin is used as an industrial solvent for a variety of materials,
including asphalt, rubber, resins, lacquers, waxes and polishes (Longacre, 1987,
Anon., 1997). The U.S. Occupational Health and Safety Administration has not
established an occupational exposure limit for tetralin. Tetralin is also a constituent
of motor fuels and is used as a substitute for terpentine and as a paint remover and
pesticide (Longacre, 1987; Cavender, 1994). The solvent is also a component
(31.5%) of CuprexR, a non-prescription human pediculocide (Drayer and
Reidenberg, 1979). Excessive dermal use of Cuprex to treat a 30-year-old male
with generalized pediculosis and extensive areas of excoriation was associated with
headache, nausea, conjunctivitis, cough, dry mouth and excretion of green urine33
(Grant et al., 1985). Tetralin-based waxes and varnishes have been held responsible
for acute CNS effects (restlessness, headache, stupor) in infants and children
(Longacre, 1987, Spencer, 2000a). Comparable acute neurotoxicity (drowsiness,
stimulus-induced hyperactivity, occasional biting of handler, tremulousness) was
noted in rats treated with AETT (Spencer et al., 1979a) and, in the present study, in
animals receiving 1,2-DAB. Biting behavior has also been reported in association
with an aminotetralin (Costall et al., 1980). Although the mechanism underlying
the acute neurotoxic actions of these compounds is unknown, it is perhaps
noteworthy that phenylaminotetralins may be agonists at a novel sigma-like site
that has neuromodulatory activity that results in increases of brain catecholamine
synthesis via activation of tyrosine (Booth et al., 1993). Sigma receptors are found
in motor and limbic areas in the brains of humans, non-human primates, and
rodents (Gonzalez and Werling, 1997). 5-Methoxy-2-[N-(2-benzamidoethyl)-N-n-
propylamino]tetralinhas a high affinity for the dopamine D2A receptor, the
dopamine D3 receptor and the serotonin 5-HT1A receptor (Homan et al., 1998).
The acute neurotoxic responses to 1,2-DAB are incidental to the principal
observation of this study, namely that repeated parenteral treatment induces
neuronal, axonal and myelin pathology associated with progressive limb weakness
preceded and accompanied by abnormal body weight gain. Examination of the
temporal evolution of the neuropathological process demonstrates that the
accumulation of neurofilaments in intraspinal motor axons and sometimes in
anterior horn cells precedes the appearance of intramyelinic edema and (secondary)
phagocyte-mediated demyelination in spinal roots. Comparable changes are seen in
lumbar dorsal spinal roots and in distal peripheral (tibial) nerves, but the latter
appearmuch laterin the pathological process. Thus, distal forelimb weakness and
hindlimb paresis seem to arise predominantly from radiculopathy (ventral root
pathology) rather than peripheral neuropathy. Whether distal nerve fibers
eventually undergo atrophy or degeneration, or both, would require animal
treatment regimens that result in a degree of clinical deficit that may be difficult to
justify on ethical grounds.The myelin changes induced by 1,2-DAB are indistinguishable from those
seen in rats treated with AETT, a compound that (with prolonged treatment)
induced a spectacular pattern of CNS and PNS vacuolar demyelination reminiscent
of status spongiosus (Spencer et al., 1979a,b). Based on the present observations, it
seems likely that 1,2-DAB and AETT-induced demyelination are equivalent,
originatesecondaryto axonal degeneration, and are followed in the region of nerve
fiber damage by axonal attenuation and remyelination. This would account for the
observation that AETT does not interfere with Schwann cell behavior during
wallerian degeneration, regeneration after crush injury, or remyelination in the
perineurial window model of primary demyelination (Sterman and Spencer, 1981).
Prolonged AETT treatment was also associated with a marked neuronal
cytoplasmic lipopigmentation (ceroid type) that was prominent in the pyramidal
cells of the entorhinal cortex, hypoglossal nuclei in the brainstem, anterior horn
cells in the lumbar spinal cord, and the spinal ganglia. The reason for the absence
of comparable neuronal and glial lipopigmentation in rats treated with 1,2-DAB is
unknown; possibly, the explanation may be the shorter period of animal treatment
with 1,2-DAB vs. AETT.
From 1960, published reports indicated n-hexane was able to induce
peripheral neuropathy in humans who were overexposed to this aliphatic
hydrocarbon solvent in the setting of either inhalant abuse or occupational exposure
(Spencer et al., 1980b). Controlled studies with rats reproduced n-hexane
neuropathy (Schaumburg and Spencer, 1976, 1978) and showed the
neuropathological substrate to be a central-peripheral distal axonopathy hailmarked
by focal axonal swellings containing excessive numbers of maloriented but
otherwise normal-appearing 10 nm neurofilaments (Spencer and Schaumburg,
1977a,b). By contrast, three hexane isomers of n-hexane were found together to
lack the ability to induce peripheral neuropathy in subchronically treated rats (Egan
et al., 1980). The explanation for the special structural relationship between n-
hexane and axonal neuropathy awaited experimental studies stimulated by an
industrial outbreak of a peripheral neuropathy attributed to methyl ethyl ketone35
acting to potentiate the neurotoxic properties of methyl n-butyl ketone (2-
hexanone) (Mendell et al., 1974). Both n-hexane and its metabolite 2-hexanone
were shown to be biotransformed to 2,5-HID, the serum levels of which accounted
for the ascending neurotoxic potency of the three compounds (Krasavage et al.,
1980). Unlike 2,5-HD and 2,5-hexanediol, neither 2,4-hexanedione nor 2,3-
hexanediol was able to induce experimental neuropathy (Spencer et al., 1978).
However, other y-diketone compounds, such as 2,5-hepatanedione, induced
peripheral neuropathy (O'Donoghue et al., 1984).
The neurotoxic potency of the 6-carbon y-diketone 2,5-HID was stepwise
increased by the addition of methyl groups, such that the potency of 3,4-dimethyl-
2,5-RD > 3-methyl-2,5-HD> 2,5-HID (Anthony et al., 1983a,b; Monaco et al.,
1990). These compounds were proposed to induce neurotoxicity by reaction with
amino groups of proteins to form pyrroles that spontaneously oxidized to form
pyrrolated polymers (Anthony et al., 1983a; DeCaprio et al., 1992). It is unclear
whether the second step is required for neurotoxicity (DeCaprio, 2000), but new
probes have been developed to examine this question (Xu et al., 2001). By contrast,
the non-y-diketones (which failed to induce peripheral neuropathy in rats) were
non-reactive with amino groups. Since pyrrole formation is apparently required for
the induction of y-diketone axonopathy, and the rate of pyrrole formation correlates
directly with the methylation status and corresponding potency of the y-diketone
species, it seems likely that this reaction is responsible for the induction of giant
axonal neuropathy (DeCapno, 2000).
Neurofilaments are hypothesized to accumulate in axonal swellings during
y-diketone treatment because the anterogradely transported neurofilament proteins
undergo progressive pyrrolation and cross-linking (Graham et al., 1985; Pyle et al.,
1992). In the case of 2,5-HID, the reactions leading to protein cross-linking are
apparently relatively slow processes that allow neurofilament protein to reach distal
axons before further anterograde transport of the altered proteins fails. The highly
potent y-diketone, 3,4-dimethyl-2,5-HD, reacts much more rapidly with amino36
groups to form methylpyrrole dimers leading to more rapid cross-linking of
proteins, thereby causing transported proteins to be rapidly modified and
neurofilament peptides to accumulate in proximal giant axonal swellings in dorsal
and ventral roots (Anthony et al., 1983b). Subsequent experiments with 3-acetyl-
2,5-HD, which forms pyrroles that are not susceptible to auto-oxidative cross-
linking, failed to cross-link tissue protein and did not appear to be neurotoxic
(Genter St. Clair et al., 1988). Although this evidence supports the proposal that the
cross-linking of neurofilament protein is the crucial step in the induction of axonal
neuropathy, pynole adduct levels at the proposed neurofilament target sites have
not been compared in 2,5-HD-treated and 3-acetyl-2,5-FID-treated animals
(DeCapno, 2000). Just as it is logical to propose that anterogradely transported
neurofilament proteins serve as the critical target of y-diketones, a protein-based
neurofilament-transport mechanism that moves anterograde in concert with
neurofilaments is also a plausible hypothetical target for these agents.
The molecular mechanisms underlying the chromogenic and neurotoxic
properties of aromatic hydrocarbons such as 1,2-DAB and AETI are under active
investigation. Both 1,2-DAB and the keto derivative of AETT have chromogenic
behaviors, but the protein adducts responsible for these reactions have yet to be
identified. One possibility for the active chromogen is Ruhemann's purple
(Spencer et al., 1980a; Zhan et al., 2001), the pigment formed in the familiar
reaction of ninhydrin with amino acids. The formation of colored adducts with
neurofilament peptides or the proteins required for their axonal transport might then
account for the neurotoxicity of 1,2-DAB. However, animals treated with ninhydnn
failed to develop global chromogenic changes and behavioral or pathologic
evidence of neurotoxicity, even though there was evidence of systemic toxicity in
the form of body weight changes and liver toxicity. Taken together, these
observations appear to be inconsistent with a ninhydrin-like mechanism for the
induction of 1,2-DAB axonopathy.
Formation of protein complexes analogous to the pynoles formed by 2,5-
HID is perhaps a more likely mechanism for 1,2-DAB neurotoxicity, and there are37
various routes that can lead to protein cross-linking. However, unreacted
(unoxidized) pyrroles, whether as monomer or dimer and without special
substitutions, do not show absorption in the visible range (Zhan et al., 2001).
Several other structures have been proposed that could account for the chromogenic
behavior: These include conjugated pyrroles or other structures derived from
pyrrole dimers that are highly colored, for example, indole and isoindole
derivatives (e.g. structures 2-5 in Nan'ya and Maekawa, 1975; Nan'ya and
Maekawa, 1977a; Nan'ya et.al., 1982), structures resembling indigo-based dyes
(Streitwieser and Heathcock, 1981; Roberts and Caserio, 1965) or structures based
on condensed tetra-pyrroles (Bourhis et.al., 1972). Resolution of the question of
relating chromogenicity to neurotoxicity is important not only to understand
molecular mechanisms of neurotoxicity but also to assess whether chromogen in
urine can serve as a useful biomarker of exposure to 1,2-DAB and other neurotoxic
aromatic hydrocarbons (Spencer et al., 2001a,b).
The potential health significance of these observations merits consideration.
While 1,2-DAB appears to be a potent neurotoxic substance, its use may be
restricted to that of a laboratory indicator for amino acids (Roth, 1971; Ebrahim
and Dakshinamurti, 1986; Bayle-Lacoste et al., 1987). The parent neurotoxic
substance, 1,2-DEB, is used as a specialty paint solvent (Welsh, 1980) and is
present in small concentrations in the jet fuels JP4 and JP8 (Hughes et al., 1982-
83), together with a number of other reportedly chromogenic aromatic
hydrocarbons. 1,2-DEB comprises approximately 7% of DEB (Gagnaire et al.,
1990), which is used as a heat-transfer fluid and in the production of vinyl benzene
(styrene) (Payan et al., 1999, Saellenfait et al., 1999). DEB is a constituent of
organic solvent mixtures (Czeski and Kostrzewski, 1995; Gagnaire et al., 1990).
It is noteworthy that the neurotoxic potency of 1,2-DEB in the rat is 5 times
greater than that of n-hexane (Gagnaire et al., 1990), a neuropathy-producing
substance that has been assigned a NIOSH time-weighted recommended exposure
limit for workroom air of 50 ppm. Formal studies should be conducted to compare
the neurotoxic potency of these compounds and their active neurotoxic metabolites(2,5-HID and 1,2-DAB). Judged solely from the proximal distribution of giant
axonal swellings induced by 1,2-DAB, a neuropathological pattern seen with 3,4-
dimethyl-2,5-HD (which is 20-30 times more potent than 2,5-HID) (Anthony et al.,
1983a), 1,2-DAB is likely to have a neurotoxic potency significantly higher than
that of 2,5-HD. This relationship will be important for the establishment of
exposure limits for 1 ,2-DEB and DEB mixtures.39
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The y-diketone analogs 1 ,2-diacetylbenzene (1,2-DAB) and 2,5-hexanedione
(2,5-HD), but not the-diketone 1,3-diacetylbenzene (1,3-DAB) or the 13-diketone
2,4-hexanedione (2,4-HD), induce neuropathological changes in the rodent central
and peripheral nervous system. The molecular targets of the neurotoxic aromatic
and aliphatic y-diketones, and of their non-neurotoxic structural analogs and
ninhydrin, are examined by assessing their differential reactivity with neural and
non-neural amino acids and proteinsin vitroandin vivo.Whereas 1,2-DAB is
chromogenic and forms polymers with amino acids (notably lysine) and proteins
(especially lysine-rich proteins), 1,3-DAB lacks these properties. Ninhydrin forms
a chromophore without evidence of protein polymerization. 1,2-DAB preferentially
targets neurofilament relative to microtubule proteinin vitroandin vivo.Based
on protein reactivity, 1,2-DAB is three orders of magnitude more potent than 2,5-
HD. Lysine-rich neurofilament protein subunits NF-H and NF-M are relatively
more susceptible than lysine-poor NF-L and 13-tubulin to 1,2-DAB. These
observations correlate with the development of proximal (1,2-DAB) and distal (2,5-
HID) neurofilament-filled axonal swellings and segregated intact microtubules
observed during systemic treatment with aromatic and aliphatic y-diketones.
KEY WORDS. y-diketone, diacetylbenzene, aromatic solvent, neurofilament,
axonopathy, chromophore, protein adducts42
INTRODUCTION
1,2-Diacetylbenzene (DAB) is the putative active metabolite of 1,2-
diethylbenzene (1,2-DEB), a minor component of aromatic solvents used in
industry. 1,2-DAB reacts with amino acids and proteins to form a blue pigment or
chromophore (Gagnaire et al., 1991). Rats treated orally or by inhalation with 1,2-
DEB or 1,2-DAB develop bluish discoloration of tissue and greenish urine. The
chemical structure(s) of the chromophore formed by reaction of 1,2-DAB with
amino acids and primary amines has been examined (Nan'ya and Maekawa, 1975,
1977; Nan'ya et al., 1982). Continued treatment with 1,2-DEB or 1,2-DAB causes
limb weakness accompanied by electrophysiological deficits consistent with
sensorimotor neuropathy and altered brainstem auditory evoked potentials
(Gagnaire et al., 1990, 1991, 1992a,b).
We have reported that the chromogenic and neurotoxic properties of 1,2-
DAB (a y-diketone) are absent in its structural analog 1,3-DAB (a ö-diketone) (Kim
et al., 2001). The aromatic y-diketone induced a pattern of neuropathology
comparable to that seen with the high-potency aliphatic y-diketone, 3,4-dimethyl-
2,5-hexanedione (DMHD) (Anthony et al., 1983b). Animals treated with daily
intraperitoneal injections of 1,2-DAB developed neurofilament accumulations in
anterior horn cells and in extreme proximal regions of motor and sensory nerve
fibers in the anterior spinal roots and dorsal root ganglia, respectively.
Ultrastructural examination of cross sections of 1,2-DAB-induced (and DMHD-
induced) axonal swellings revealed densely packed neurofilaments and islands of
segregated microtubules, mitochondria, and vesicles. Beginning pathological
changes in lumbar spinal roots of 1,2-DAB-treated rats occurred in the absence of
overt nerve fiber atrophy or degeneration in sciatic and tibial nerves (Kim et al.,
2001).
Neurofilaments are composed of cytoskeletal triplet proteins that move
anterogradely from their site of synthesis in the nerve cell body along the axon to
the nerve terminal (Hoffman and Lasek, 1975). Neurofilament (NF) transport is43
blocked by systemic treatment with aliphatic y-diketones, which cross-link NF (and
other) proteins to form polymers (reviewed by DeCaprio, 2000). Low potency 2,5-
hexanedione (2,5-HID) and high potency DMHD react with proteins slowly and
rapidly, respectively, and, in turn, arrest NF transport distally (nerve) and
proximally (spinal roots), respectively (Anthony et al., 1983a,b). Formation of
pyrrole adducts with E-amino groups in lysine residues of protein, particularly NF
protein, has been suggested as the critical step in the genesis of aliphatic y-diketone
axonopathy (Graham et al., 1982; DeCaprio et al., 1982). The diketone-NF pyrrole
adducts are believed to undergo secondary covalent intermolecular NF-NF cross-
linking (Graham et al., 1982). The cross-linked NIFs are unable to move
anterogradely along the axon and consequently accumulate in focal axonal
swellings visible by light microscopy (Anthony et al., 1983b). Rats treated with
2,5-HID, which is less reactive than DMIID, showed preferential reduction of the
heavy NF protein (NF-H) (Carden et al., 1986), or all three NF protein subunits
(Lapadula et al., 1986), and accumulation of higher-molecular-weight products
immunoreactive with NF-specific antibodies. 3-Acetyl-2,5-HD, which forms
pyrroles that are not susceptible to auto-oxidative cross-linking, failed to cross-link
tissue protein and did not cause neurofilamentous axonal swelling (Genter St. Clair
et al., 1988). These findings suggest that polymerization of target proteins is a
required step for axonal neurotoxicity.
The present studies compare the neural targets of aromatic and aliphatic y-
diketones by examining their differential reactivity with neural and non-neural
amino acids and proteinsin vitroandin vivo,and the effects of 1,2-DAB on protein
function. The properties of these compounds are compared with that of ninhydrin,
a chromogenic amino acid reagent that fails to induce neurofilamentous axonopathy
in systemically treated rats (Kim et al., 2001). The studies suggest that aromatic
and aliphatic y-diketones have common neural targets.MATERIALS AND METHODS
Chemicals
1,2-DAB (99% pure), 1,3-DAB (97%), and ninhydrin (97%) were
purchased from Aldrich Chemical Co. (Madison, WI) and dessicated at RT (1,2-
DAB) or stored at 4°C (1,3-DAB). 2,5-HD (94% pure) and 2,4-FID (94%) were
purchased from Eastman Chemical Co., Rochester, N.Y. Chemical purity was
confirmed by gas chromatography-mass spectrometry (GC-MS). Purified amino
acids (99+%), reduced glutathione (GSH), non-neural proteins (crystalline) and
enzymes (lyophilized) were obtained from Sigma Chemical Co. (St. Louis, MO)
and neural proteins (1mg/mi solutions) from Cytoskeleton Co., Denver, CO.
Proteins included: bovine serum albumin (BSA), crystalline bovine pancreatic
ribonuclease (RN), bovine spinal cord NF proteins (mixture of NF-H, NF-M and
NF-L subunits), and bovine brain tubulin.Enzymes included rabbit muscle
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and lactate dehydrogenase
(LDH). All other chemicals used were of analytical grade.
Animals
Male Sprague-Dawley rats, weighing 175-225 g on arrival, were housed at
20°C on a 12h112h light-dark cycle. Purina rat chow and waterwere supplied ad
libitum. Animals were acclimated individually in home cages for 5 days. Eleven
rats were used to examine the action of DAB isomers on peripheral nerve in vivo,
and the spinal cord was removed from an additional 20 animals to study the protein
reactivity of these agents in vitro. These studies are described below.45
Amino acid and protein chromogenicity
We examined the differential reaction in vitro of neurotoxic and non-
neurotoxic DAB isomers with 22 protein and non-protein (ornithine, y-
aminobutync acid) amino acids. Test articles were dissolved in 0.1M phosphate
buffer (pH 7.4). Equal volumes of each test article and either 1,2-DAB or 1,3-DAB
(1mM) were incubated at 37°C for 15, 30 or 60 mm. Absorbance of the resulting
purple/blue color was determined between 350 and 650 nm in a scanning
spectrophotometer (Perkin Elmer Lambda Bio UV/VIS), with a peak absorbance at
540 nm. The intensity of the color formed from the reaction in triplicate of
1,2-DAB or 1,3-DAB with lysine, glycine, ornithine, y-aminobutyric acid (GABA)
or cysteine (negative control) was measured after incubation at 37°C for 15 mm,
30 mm or 60 mm.
We used L-lysine (the most reactive amino acid) and BSA (a representative
protein) to compare the chromogenic reaction of DAB isomers. BSA (0.Smg/ml)
and L-lysine (0.5mg/ml) were individually reacted with lmgIml 1,2-DAB or 1,3-
DAB for lh at 37°C in 0. 1M phosphate buffer, pH 7.4. The peak pattern of the
chromogen formed in each reaction was determined as described above.
Protein reactivity and polymer formation
We examined the ability of neurotoxic and non-neurotoxic aliphatic and
aromatic diketones to form polymers with test proteins, namely BSA (MW-67,000)
and RN (MW -43,000). In addition, BSA was studied in the presence and absence
of GSH. Polymer formation with diketones was also compared with that of
ninhydrin, which also forms a chromophore with amino acids and proteins but
lacks systemic neurotoxicity (Kim et al., 2001). The following incubations were
performed: (a) BSA (16 mg/ml in 0.1M phosphate buffer, pH 7.4) was incubatedfor 30 mm. at 37°C with 1,2-DAB (1,2,3,4 or 5mIVl) or 1,3-DAB (5mM); (b)an
equivalent concentration of RN was incubated for 5, 10 or 15 mm. at 37°C with
25mM 1,2-DAB or 1,3-DAB in phosphate buffer (0.1M, pH 7.4). Under
comparable conditions, BSA and RN were individually incubated in an equivalent
volume of buffer (control); (c) BSA was incubated for 30 mm. with 2,5-HID (2M),
2,4-HID (2M), 1,2-DAB (2m11V1), 1,3-DAB (2mM), or ninhydrin (0.5 and 2m1V1) in
0.1M phosphate buffer pH 7.4 at 37°C. In addition, BSA in the presence or
absence of GSH (5 or 10mM) was incubated with 1,2-DAB (5mM) in 0.IM
phosphate buffer pH 7.4 for 30 mm. at 37°C. Aliquots of reacted protein (lOj.tg)
were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) (Laemmli, 1970).
GAPDH and LDH reactivity
We compared the protein reactivity and enzyme activity of GAPDH and
LDH after their individual treatment in vitro with DAB isomers. Lyophilized
GAPDH (lOOj.tgI2Oj.xl of 0. 1M pyrophosphate buffer, pH 8.5) or LDH (100pg/20pJ
of 0.1M phosphate buffer, pH 7.2) was incubated for 30 mm. at 37°C with 1,2 or
5mM 1,2-DAB or 1,3-DAB in the same buffer. Controls were incubated under
identical conditions in the respective buffer alone. Aliquots of reacted GAPDHor
LDH solution were examined spectrophotometncally for enzyme activity using the
method of Sabri (1983) as described below. Additional aliquots (6tg protein)were
used for SDS-PAGE.
Neural protein reactivity
We examined the differential protein reactivity of DAB isomers and
ninhydrin with purified tubulin and NP proteins containing all three subunits. Each
purified protein (6tg) was treated for 30 mm at 37°C (pH 7.4) with 1, 2 or 5mM47
1,2-DAB, 1,3-DAB, or ninhydrin in 0.1M phosphate buffer (pH 7.4) (3-5 trialsper
compound). In controls, DAB isomers were replaced by an equivalent volume of
buffer. The relative reactivity of NF proteins with DAB isomers was compared in a
single trial with that of 2,5-HD or 2,4-HD (lmM-2.OM). Samples of reacted
protein were subjected to SDS-PAGE.
Spinal cord protein reactivity in vitro
We determined the DAB reactivity of neural cytoskeletal elements in spinal
cord tissue, the locus of early pathological changes in animals treated with 1,2-
DAB. Rats were decapitated by guillotine and the spinal cord expelled with ice-
cold 0. 1M phosphate-buffered saline by the method of deSousa and Horrocks
(1979). The lower half of the spinal cord tissue was stored at -80°C.
Thawed spinal cord tissue was cut into 2-mm lengths on a chilled dissecting
board. Tissue was incubated with individual DAB isomers in 0. 1M phosphate
buffer (pH 7.4, 37°C) for different times (15, 30, 60mm) and at varying
concentrations (0.1, 0.5, 1, 2, 5, 10mM). Incubated tissue was twice rinsed with
ice-cold 0.1M phosphate buffer and homogenized on ice for 10 sec. with 8Murea
containing complete protease-inhibitor cocktail (one tabletl5Oml buffer) (Roche
Molecular Biochemicals, Indianopolis, IN). The homogenate was centrifuged at
10,000 x g for 5 mm at 4°C and the supernatant collected. Protein concentration in
the supernatant was determined using the Coomassie-plus-200 protein reagent
(Pierce Co., Rockford, IL) according to the manufacturer's instructions. Aliquots
(6tg total protein) were subjected to SDS-PAGE.
Sciatic nerve protein reactivity in vivo
We examined the reactivity of DAB isomers in living peripheral nerve
tissue. High DAB concentrations for short periods were used to minimize thetreatment period and to maximize the ability to detect and identify susceptible
neural proteins. Animals were placed on a warming pad and deeply anesthetized
by inhalation of halothane or isofluorane. The thigh of the anesthetized animal was
shaved bilaterally and the exposed skin cleaned with isopropanol. The sciatic nerve
was surgically exposed in the thigh, connective tissue surrounding the nerve gently
removed, and a 1-cm piece of Parafilm slipped under the nerve to form a fluid trap.
Exposed nerves (-1 cm) were each continuously bathed for 5 mm with a total of
-1ml of the test article (n=22). Test agents included 1,2-DAB (0, 2, 5, 25 or 50
mM) or 1,3-DAB (25 mlvi) in isotonic saline + 2% acetone at RT. Treated nerves
were excised from animals, which were then immediately terminated by anesthetic
overdose. Excised tissue was placed on an ice-cold dissecting board, the
epineurium and endoneurial blood vessels removed, and the remaining
intrafascicular tissue (comprising nerve fibers and endoneurial connective tissue)
stored at -80°C until use. Methods of homogenization, centrifugation, protein
determination and SDS PAGE were those employed for spinal tissue.
SDS-PAGE and Western blotting
Six micrograms of reacted protein and low molecular weight- or high
molecular weight protein markers (Bio-Rad, Richmond, CA) were separated by
SDS-PAGE (a 4-15% gradient polyacrylamide gel for spinal cord tissue and 4-20%
for sciatic nerve tissue) using optimal separation conditions (80V for 15mm plus
100V for 1-2 h) and a Mini Protein II Gel Apparatus (Bio-Rad, Richmond, CA).
Gels were stained with 0.2% Coomassie blue for -lh to visualize native protein and
diketone polymers formed therefrom. Visualization of NF proteins in neural tissue
used an immunoblotting technique employing monoclonal mouse antibodies to
13-
tubulin, NF-H (200kD, clone RT97), NF-M (l6OkD, clone NN18) and NF-L
(7OkD) subunits (Chemicon International Inc., Temecula, CA). For thispurpose,
electrophoresed proteins were transferred to polyvinylidene fluoride (PVDF)
membranes using Trans-Blot Electrophoretic Transfer Cell (Bio-Rad, Richmond,CA), according to manufacturer's instructions. PVDF membranes were stained
with Ponceau-S solution (Fiuka, Milwaukee, WI) to check for successful transfer of
separated proteins. PVDF membranes were washed 3X with PBS-T (0. 1M
phosphate-buffered saline plus 0.1% Tween-20, pH 7.4) and blocked for lh with
5% non-fat milk in PBS-T or blocking agent (3% casein in PBS-T, Amplified Opti-
4CN Detection Kit, Bio-Rad, Richmond, CA). Membranes were incubated with
constant shaking for lh at RT with the appropriate dilution (3000-10,000 X) of
primary monoclonal antibody in 1% BSA in PBS-T. Incubated membranes were
washed twice with PBS-T before applying secondary antibody conjugated with
either (a) horseradish peroxidase (HRP) for detection on X-ray film (Eastman
Chemical Co., Rochester, N.Y.) using a chemiluminescence substrate (Pierce,
Rockford, IL) or (b) biotinylated goat anti-mouse IgG for colorimetric detection
after treatment with streptavidin-HRP amplifying reagent (Bio-Rad, Richmond,
CA).
Enzyme assays
The glycolytic enzymes GAPDH [E.C. 1.2.1.12] and LDH [E.C. 1.1.1.27]
were used as convenient testbeds to assess whether changes in protein integrity
correlated with alterations in protein function as measured by enzyme activity.
The enzyme activities of GAPDH and LDH were assayed by the method of Sabn
(1983).
For the GAPDH assay, 20j.tl of 5mg/mi (100tg) of lyophilized enzyme
dissolved in 0.1M pyrophosphate buffer (pH 8.5) was incubated for 30 mm. at
37°C with 20 tl of 1,2-DAB or 1,3-DAB (final concentration 1, 2 or 5mM) in the
same buffer. Control enzyme samples were identically incubated with buffer alone.
The reaction was stopped by cooling with ice and the solution immediately diluted
loxwith buffer. Enzyme activity determined spectrophotometrically at 340 nm by
the rate of reduced nicotinamide adenine dinucleotide (NADH) formed per mm50
from the reduction of NAD in the presence of substrate (glyceraldehyde-3-
phosphate), glycolysis uncoupler (sodium arsenate) and suithydryl agent
(dithiothreitol).
For the LDH assay, 1OOtg of lyophilized enzyme dissolved in 0.1M
phosphate buffer (pH 7.2) was incubated at 37°C for 30 mm. with 20 tl of 1,2-
DAB or 1,3-DAB (final concentration 1-SmIvI) in the same buffer. Control enzyme
samples were identically incubated with buffer alone. Incubated samples were
placed cooled on ice and diluted 100X with ice-cold buffer prior to LDH assay.
LDH activity was assayed spectrophotometrically by measuring the rate of NADH
decrease at 340nm in the presence of pyruvate.RESULTS
Amino acid reactivity
51
1,2-DAB, but not 1,3-DAB, formed a blue pigment (chromophore) with
selected amino acids (Table). Spectrophotometric analysis of the chromophore
revealed three peaks; the peak at 540 nm was the most consistent and most
prominent at pH 7.0. Under these conditions, the rate and amount of chromophore
formation was directly dependent on the amino acid, the concentration of 1,2-DAB
and the incubation temperature. Of the 22 amino acids tested, 1,2-DAB reacted
most rapidly with L-lysine and other primary amines. Pigment color with L-lysine
varied with hydrogen ion concentration and ranged between pink (pH 2.4), purple-
blue (pH 5-7) and brown (pH 11.0). Chromophore density varied with time of
incubation: for example, L-lysine and ornithine showed a similar intensity of
chromophore at 60 mm, but not at 15 mm, when L-lysine intensity was two-fold
that of ornithine. Glycine and GABA reacted similarly at all time points tested.
The reactivity of other amino acids with 1,2-DAB (n=1/amino acid) was as follows:
L-histidine > L-asparagine > L-methionine = L-glutamine > L-arginine = L-
phenylalanine > L-aspartic acid = L-leucine, L-serine, L-alanine, L-glutamic acid,
L-tryptophan, L-cysteine > L-threonine = L-isoleucine, L-tyrosine, L-valine and L-
proline. As expected, no chromophore was detected with 1,3-DAB.52
Table 3.1. Chromogenic reactivity of selected amino acids with diacetylbenzene
(DAB) isomers.
Amino Acid 1,2-DAB 1,3-DAB
15mm 30mm 60mm 60mm
L-Lysine 2.04±0.023.22±0.02 3.51±0.02 0.00
Ornithine 0.99±0.022.80±0.01 3.56±0.01 0.00
Glycine 0.95±0.012.21±0.02 3.32±0.04 0.00
GABA 0.86±0.031.93±0.03 3.02±0.02 0.00
L-Cysteine 0.00 0.00 0.02 0.00
Values represent mean absorbance ± standard deviation at 540nm. In triplicate,
0.5m1 of amino acid solution (0.1M, pH 7.0) was incubated with 0.5 ml of 1,2- or
1,3-DAB (1mM) at 37°C for the stated times. L-Lysine, glycine, y-aminobutryic
acid (GABA) and ornithine, a non-protein amino acid and higher homologue of L-
lysine, were the most reactive of 22 tested amino acids. L-Cysteine was among the
least reactive of amino acids tested.
Protein reactivity
BSA and RN served as test articles to assess the protein reactivity of DAB
isomers. Spectrophotometric analysis of the chromophore formed between 1,2-
DAB and BSA revealed a lysine-like pattern of peaks with the most prominent
peak at 540 nm at pH 7.4. Treatment with 1,2-DAB, but not 1,3-DAB, resulted in
reduced staining intensity of test protein bands and appearance of protein adducts
of higher molecular weight (dimers, trimers etc.) (Fig.3.1).A 1,2-DAB1,3-DAB B 1,2-DAB1,3-DAB
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Figure 3.1. In-vitro effect of diacetylbenzene (DAB) isomers on test proteins
bovine serum albumin (BSA) and ribonuclease (RN) analyzed by SDS-PAGE. (A)
BSA (16mg/mi) was incubated for 30 mmat 37°C with 1,2-DAB (1-5mM) or 1,3-
DAB (5mM). 1,2-DAB, but not 1,3-DAB, reduced the native protein and
poiymenzed BSA in a concentration-dependent manner. (B) RN (16mg/mi) was
incubated with buffer or 25mM 1,2-DAB or 1,3-DAB for 5-15mmat 37°C. 1,2-
DAB, but not 1,3-DAB, caused a temporal reduction of native protein and increase
of 3OkD and 45kD dimers and trimers, respectively. (C) BSA (16mg/mi) was
incubated at 37°C for 16h with DAB isomers, hexanedione (lID) isomers, or
ninhydrin at the stated concentrations. Insoluble protein adducts formed with 2,5-
HD and 1,2-DAB remained on the top of the gel, with the native BSA band
proportionately decreasing in staining intensity. No adducts were seen with
ninhydrin (Ni, 2,4-HID or 1,3-DAB. (D) In the presence of glutathione (5 and
10mM) (GSH5, GSHIO), 1,2-DAB did not decrease the intensity of BSA
(10mg/mi) or trigger the formation of BSA-related polymers.These changes were prominent after 30 mm. of BSA incubation with 1mM 1,2-
DAB and concentration-dependent up to 5mM (Fig. 3. 1A). There was a gradual
reduction of the intensity of RN bands (Fig. 3. 1B) and the appearance of protein
adducts of high molecular weight in 1,2-DAB-treated samples (Fig. 3.1A,B).
Native protein reduction and corresponding polymer formation was more
pronounced with 1,2-DAB (2mM) than 2,5-HID (2M); no clearcut changes were
evident with equimolar concentrations of ninhydrin or of the corresponding non-
chromogenic and non-neurotoxic isomers 1,3-DAB and 2,4-HID, respectively (Fig.
3.1C). When BSA was incubated with 1,2-DAB in the presence of GSH, protein
reactivity failed to occur as judged by the absence of chromophore formation,
preservation of native protein, and absence of high molecular weight species (Fig.
3.1D).
GAPDH and LDH activity
1,2-DAB, but not 1,3-DAB, caused the formation of high molecular weight
species and inhibited the enzyme activity of test proteins (GAPDH, LDH) in a
concentration-dependent manner(Fig. 3.2). The staining intensity of high
molecular weight species increased for both GAPDH (Fig. 3.2A) and LDH (Fig.
3.2B) over the range of 1-5mM. Incubation of these proteins with 1,2-DAB for 30
mm. resulted in a mean loss of enzyme activity of >50% (lmM),-85% (2mM) and
100% (5 mM) for GAPDH (Fig. 3.2C) and --20%, --30% and -P90%, respectively,
for LDH (Fig. 3.2D).A 1,2-DAB 1,3-DAB B 1,2-DAB 1,3-DAB
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Figure 3.2. (A,B) Effect of diacetylbenzene (DAB) isomers on the protein state
(SDS-PAGE) and enzyme activities of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and lactate dehydrogenase (LDH) after treatment in vitro with the test
agents. One hundred microgram of GAPDH or LDH in 20j..tl buffer were incubated
for 30mmat 37°C with 1-5mM 1,2-DAB orl,3-DAB, or an equivalent volume of
buffer (control). 1,2-DAB, but not 1,3-DAB, produced high molecular weight
derivatives of GAPDH (A) and LDH (B) in a concentration-dependentmanner.
(C,D) Enzyme activity of these proteins decreased (GAPDH > LDH) with
increasing 1,2-DAB concentration. *p <0.0001. 1,3-DAB producedno significant
changes in enzyme activity.Neural protein reactivity
1,2-DAB, but not 1,3-DAB, reacted with purified NF proteins (NF-H, NP-
M, NIF-L) in a concentration-dependent manner (Fig. 3.3). At 1-5 mM 1,2-DAB, a
qualitative inspection of band densities revealed greater reductions in NF-H and
NF-M than in NF-L, with corresponding increases of high molecular weight
proteins (Fig. 3.3A). By contrast, under the same conditions, 1-5mM 2,5-HD had
no detectable effect (Fig. 3.3C), and changes were only seen at 2M 2,5-HD (Fig.
3.3D). No reactivity was seen with 2,4-HID (Fig. 3.3C,D). Reductions of NF
subunit staining intensity were evident in the presence of ninhydrin; however,
protein bands of high molecular weight were not detectable (Fig. 3.3E). No
changes were evident when purified 13-tubulin was incubated with 1 or 2 mM 1,2-
DAB; there was some reduction in the density of the protein band at 5 mIVI 1,2-
DAB relative to 1,3-DAB (Fig. 3.3B). Ninhydrin produced little or no detectable
change in f3-tubulin staining (Fig. 3.3F).57
Figure 3.3. In-vitro effect of ninhydrin, diacetylbenzene (DAB) isomers or
hexanedione (HD) isomers on purified neurofilament (NF) triplet proteins and
tubulin. Six micrograms of each protein were treated with the test article or buffer
(control) for 30 mm at 37°C and resolved by SDS-PAGE as described in Methods.
(A) Treatment of NF with 1,2-DAB (1-5mM), but not with 1,3-DAB or buffer
(control), resulted in a concentration-dependent decrease in intensity of native
triplet proteins (NF-H and NF-M > NF-L), with corresponding formation of
increasing amounts of high molecular weight proteins. (B) Treatment of 3-tubulin
with 1,2-DAB, 1,3-DAB or buffer was without significant effect. (C,D) Treatment
of NF with 2M 2,5-HD, but not with lower concentrations of 2,5-HID or with 2,4-
HID (lmM-2M), or with buffer (control), resulted in a marginal decrease in
intensity of native triplet proteins. (E) Ninhydrin and 1,2-DAB reduced native NF
protein in a concentration-dependent manner, but high molecular weight species
(top of gel) were seen only with the higher concentrations of 1,2-DAB. (F)
Ninhydrin and 1,2-DAB were largely unreactive with 3-tubulin.A 1,2-DAB 1,3-DAB
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Spinal cord protein reactivity in vitro
1,2-DAB, but not 1,3-DAB, altered NF subunit proteins in a manner that
was both concentration -dependent (Fig. 3.4) and time-dependent (Fig. 3.5).
Incubation of spinal tissue with increasing 1,2-DAB concentrations for 30 mm.
resulted in corresponding reductions of band intensities of NE-H, NF-M and NF-L
(Fig. 3.4A-C). Similarly, incubation of tissue with 2mM 1,2-DAB for 15-60
min.produced corresponding increases in high molecular weight proteins that were
recognized by monoclonal antibodies to individual NF subunits (Fig. 3.5A-C).
Tubulin failed to show reactivity and form polymers with 1,2-DAB when spinal
tissue was incubated up to 60 mm. with 2mM 1,2-DAB (Fig. 3.4D, 5D). However,
high molecular weight protein immunoreactive to anti-3-tubulin was evident after
treatment with 10mM 1,2-DAB for 30mm.(Fig. 3.4D).A 1,2-DAB1,3-DAB III
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Figure 3.4. Western blots of rat spinal cord slices incubated with different
concentrations (0.1-10mM) of diacetylbenzene (DAB) isomers or buffer (control)
for 30mm. at 37°C. Six micrograms of protein from each sample were resolved by
SDS-PAGE. Proteins were transferred to PVDF membranes as described in
Methods. Blots were probed with (A) anti-neurofilament H (NF-H) monoclonal
antibody; (B) anti-neurofilament M (NF-M) monoclonal antibody; (C) anti-
neurofilament L (NF-L) monoclonal antibody, and (D) anti--tubulin (3-TU)
monoclonal antibody. (A) Native protein was reduced and high molecular weight
proteins were formed selectively when NF-H was treated with 1,2-DAB but not
1,3-DAB. (B,C) Immunostaining for NF-M and NF-L was reduced by 5 or 10mM
1,2-DAB but not by equivalent concentrations of 1,3-DAB. (D) Inimunostaining
for fE-tubulin appeared unaltered up to 5mM 1,2-DAB and 10 mM 1,3-DAB.
Evidence of high molecular weight derivatives of f3-tubulin was seen with 10mM
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Figure 3.5. Western blots of rat spinal cord slices incubated for varying period of
time (0-60 mm) with 2mM diacetylbenzene (DAB) isomers or buffer (control) at
37°C. SDS-PAGE and immunostaining are as described in figure 4 legend. (A-C)
All NF subunit blots showed a temporal increase of NF polymers of high molecular
weight after treatment with 1,2-DAB but not 1,3-DAB or buffer. (D) No polymers
of 13-tubulin (3-TU) were seen either 1,2-DAB or 1,3-DAB.62
Sciatic nerve protein reactivity in vivo.
Bathing intact sciatic nerve in 1,2-DAB, but not in 1,3-DAB, selectively and
differentially changed the pattern of cytoskeletal proteins recognized by
monoclonal antibodies specific for NF proteins (Fig. 3.6A,B,D), with no apparent
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Figure 3.6. Effect of diacetylbenzene (DAB) isomers (2-50mM) or vehicle
(phosphate-buffered saline) on intact rat sciatic nerve bathed in vivo for 5 mmat
RT. Western blot of 6 pg intrafascicular tissue proteins separated on 4-20% SDS-
PAGE and immunoprobed with anti-neurofilament (NF) peptide (NF-M, NF-L) or
anti-13-tubulin (3-TU) monoclonal antibodies. (A) 1,2-DAB treatment induced a
concentration-dependent increase of immunostaining corresponding to high
molecular weight derivatives of NF-M. (B) Immunostaining with anti-NF-M
showed polymer formation with 1,2-DAB but not with 1,3-DAB. (C, D) Polymers
of -tubulin and NF-L were not seen after treatment with either 1,2-DAB or 1,3-
DAB.63
changes intubulin (Fig. 3.6C). Formation of high molecular weight species of
Nf-M was evident in sciatic nerve tissue treated with 1,2-DAB, but not 1,3-DAB
(Fig 3.6 A,B).DISCUSSION
The present findings reveal a robust relationship among DAB structure,
amino acid reactivity, targeting of neural (NF) and non-neural (GAPDH, LDH)
protein structure and function, respectively, and chromophore formation and
neurotoxicity (axonopathy) potential. Whereas the neurotoxic aromatic y-diketone,
1,2-DAB, is a chromogenic amino acid and protein reagent, the non-neurotoxic y-
diketone, 1,3-DAB, lacks both properties. 1,2-DAB targets NF (relative to
microtubule) proteins in vitro and in vivo at markedly lower concentrations than the
corresponding neurotoxic aliphatic y-diketone 2,5-HID. Neurofilament protein
subunits NF-H and NIF-M are more susceptible than NF-L and 3-tubu1in to 1,2-
DAB. These observations correlate with the proximal (1,2-DAB) and distal (2,5-
HID) induction of NF-filled axonal swellings and segregated intact microtubules
during systemic treatment with these aromatic and aliphatic y-diketones,
respectively. These phenomena do not occur after comparable exposure to their
corresponding non-pyrrole-forming, non-neurotoxic isomers (1,3-DAB, 2,4-HD) or
to ninhydrin (Spencer et al., 1978; DeCaprio et al., 1982; Kim et al., 2001).
Amino acid and protein reactivity
1,2-DAB reacts with various amino acids and proteins, including those
present in human and animal skin, to form colored pigments (Nan'ya et al., 1977;
Kim et al., 2001). Among the amino acids tested here, those containing a primary
amino groupsuch as lysine and glycine --- react most strongly with 1,2-DAB to
form a purple-blue chromophore at pH 7.0. Basic amino acids, such as arginine and
histidine, are much less reactive, while the thioamino acid cysteine, is essentially
unreactive with 1,2-DAB under these conditions. While prolonged incubation of
cysteine with 1,2-DAB produces a chromophore closely resembling the pigment
formed between 1,2-DAB and human skin, the latter reaction is near-instantaneous
and therefore difficult to attribute to cysteine, as proposed by Nan'ya and Maekawa65
(1977b). Lysine more than any other amino acid is a likely candidate for rapid
reaction with 1,2-DAB because of the presence of its exposed (and therefore
reactive) s-amino group. Similarly, 2,5-HD is reported to target the s-amino group
of lysine to form pyrroles, the first step in the formation of cross-linked proteins
(Graham et al., 1982; DeCaprio et al., 1982). Just as omithine forms insoluble
polymers with 2,5-HD (Yamamoto et al., 1994), we find that reactive amino acids
(lysine) and proteins (BSA) form a polymer (solid or rubbery, respectively, after
prolonged incubation) that is insoluble in water, common organic solvents and
SDS. The formation of polymers by reaction of 2,5-HD with proteinsin vitro is
blocked by GSH, which is thought to undergo cross-linking and thereby prevent
pyrrole oxidation and polymerization (Zhu et al., 1995). GSH also blocks the
formation of chromophore and polymers formed between BSA and 1,2-DAB. Since
lysine forms a blue pigmentin vitroboth in the presence of oxygen and in its
absence(N2atmosphere, up to 24h, RT, pH 7.0), we are uncertain whether the
chromophore corresponds to the proposedl,2-DAB-related isoindole monomer (see
below) or a polymerized derivative.
The chemical structure of the chromophore formed between 1,2-DAB and
amino acids/proteins has yet to be established. However, this is unlikely to be
related to the bluish chromophore (Ruheman's purple) formed between ninhydrin
and amino acids because ninhydrin (a) fails to form high molecular weight protein
adducts with BSA, NF, 3-tubulin), and (b) does not induce behavioral and
pathological indices of neurotoxicity in systemically treated animals (Kim et al.,
2001). The blue chromophore formed by the aromatic ydiketone neurotoxin 1,2-
DAB compares with the orange-reddish, pyrrole-related pigment associated with
the aliphatic ydiketone 2,5-HID (Johnson et al., 1995). Nan'ya and associates have
proposed a number of structures for the 1,2-DAB-derived chromogenic polymer,
including the pyrrole-related isoindole structure shown in figure 7 (Nan'ya and
Maekawa, 1975, 1977a,b; Nan'ya et al., 1982). Our preliminary GC-MS studies
show that lysine and 2,5-RD (0.1M) or 1,2-DAB (0.1M), under conditions of high
pH (- 11), form identical elution peaks (21.73>21.07> 22.06/mm) andfragmentation patterns corresponding to the pyrrole moiety of both chromophores.
Similarly, the urinary chromophore collected from rats treated with 1,2-DAB (20
mg/kg/d i.p. for 8-9 days) demonstrates the presence of pyrrole by GC-MS (M-S
Kim and J. Muniz et al., unpublished data).Others have shown that 2,5-HD forms
pyrrole adducts with BSA, ovalbumin, RN and NF protein (Graham et al., 1982;
Decaprio et al., 1982; Anthony et al., 1983a; Yan et al., 1996). These pyrrolated
proteins are proposed to undergo further oxidative reactionin vitroto form
secondary, cross-linked derivatives (dimers and higher polymers). Based on lysine
(chromogenicity) and protein reactivity (polymer formation), the present findings
show that 1,2-DAB is at least three orders of magnitude more reactive than 2,5-HD.
Given that the rate of y-diketone-induced pyrrole formation and polymerization are
related to neurotoxic potency for axonopathy, as shown for 2,5-HID (low
reactivity/potency) versus DMHID (20-30X greater reactivity/potency than 2,5-
HID) (Anthony et al., 1983a), it is likely that the neurotoxic potency of 1,2-DAB
far exceeds that of 2,5-HID. It is noteworthy that whereas axonal neurofilaments
accumulate in distal axons of animals treated with 2,5-HID (Spencer and
Schaumburg, 1977a,b), both 1,2-DAB and DMHD cause proximal accumulations,
presumably because these NF proteins are rapidly cross-linked and polymerized
and cannot be transported further along the axon (DeCaprio et al., 1982; Graham,
1995). Formal toxicology studies are needed to compare the protein reactivity and
neurotoxic potency of 2,5-HD and 1,2-DAB; these appear to be the active
neurotoxic metabolites of the organic solvents n-hexane and 1 ,2-diethylbenzene,
which have a five-fold difference in neurotoxic potency (Gagnaire et al., 1990).
The protein reactivity of 1,2-DAB and formation of high molecular weight
adducts appear to correlate with the lysine content of the proteins studied here(see
ProtParam database at http://www.expasy.chl). Bothin vitroand in vivo, rat NF-H
(13-16% lysine) and NF-M (11-12%) formed polymers more readily than either
NF-L (6-7%) or tubulin (3-4%). Other potential protein targets involved in
anterograde axonal transport include the rat microtubule-associated protein tau (7-
10% lysine), the rat motor proteins kinesin (chain A, 8%; chain B, 12%) and dynein67
(8%), and the rabbit glycolytic enzymes GAPDH (8%) and LDH (7-8%). While
GAPDH and LDH are similarly reactive with 1,2-DAB in vitro, the enzyme
inhibition at equimolar concentrations (1 mM, 30 mm.) of GAPDH is greater
(-50%) than that of LDH (-P20%). These observations show that 1,2-DAB may
differentially impact protein structure and function. Presumably, changes in
protein function (e.g. GAPDH and LDH enzyme activity) relate to 1,2-DAB-
reactive lysine moieties at the active site.
While the reaction of 1,2-DAB with proteins is non-specific, the present
studies demonstrate important differences in reactivity and functional
consequences. The test proteins GAPDH and LDH are both chromogenically
reactive in vitro, but enzyme inhibition at equimolar concentrations (1 mM) was
one-half and one-fifth, respectively.
Mechanismsofneurotoxicity
The molecular mechanisms underlying the neurobehavioral effects of 1,2-
DAB, such as hyperactivity, drowsiness, are unknown. 1,2-DAB might react with
free amino acids that subserve neurotransmitter function in the central nervous
system (CNS). The CNS neurotransmitters glycine and GABA are highly reactive
with 1,2-DAB as judged by the rate and amount of chromophore formation in vitro.
Free GABA is the dominant brain inhibitory neurotransmitter. Free glycine, which
serves as an important inhibitory neurotransmitter in the brainstem and spinal cord,
binds to strychnine-sensitive receptors that regulate motor neuron activity (Hunter
et al., 1989). Very low levels of glycine are also required to activate ion channels
associated with the neurotransmitter receptor sensitive to N-methyl-D-aspartate
(NMIDA), one of several glutamate receptors that mediate CNS excitation (Kandel
et al., 2000). Reduction in the level of free glycine through isoindole formation
with 1,2-DAB might therefore be expected to impact NMIDA-receptor function
(decreased excitation state) before glycinergic and GABA receptor function(increased excitation through reduced inhibition). This provides a possible
explanation for the observation that 1,2-DAB-treated rats become both drowsy and
hyperreactive to stimuli.
Neuropathological changes in spinal cord and spinal roots correlate with the
onset of limb weakness in 1,2-DAB-treated rats (Kim et al., 2001). Focal NF-filled
axonal swellings in the initial segments of motor nerve fibers are very early
features. Comparable neuropathological changes are found in rats treated with
DMHD or f3j3'-iminodipropionitrile (IDPN) as a result of the arrest of slow
anterograde NF transport (Griffin et al., 1978; Sickles, 1989). The swollen axon
disrupts the integrity of the myelin sheath, which is required for maintenance of
normal impulse conduction. Since peripheral nerves distal to the sites of axonal
swelling are relatively normal at this time (no prominent atrophy or wallenan-like
degeneration), the beginning neuropathological picture during 1,2-DAB treatment
is more consistent with a radiculopathy than a neuropathy. However, treatment
with 1,2-DAB or 1 ,2-DEB does result in a decrease of both motor andsensory
nerve conduction velocities of peripheral nerve fibers in the rat tail (Gagnaire et al.,
1990, 1991). DMHD, another potent y-diketone that rapidly cross-links target
proteins (notably neurofilaments), causes giant axonal swellings to form in
proximal axons (Anthony et al., 1983a). Cross-linking of NF proteins and their
anterograde transport arrest likely account for the formation of intraspinal and
spinal root giant axonal swellings and the onset of limb weakness in DMHD
(Anthony et al, 1983b) and in 1,2-DAB neurotoxicity (Fig 3.7)./LO
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Figure 3.7. Structure and hypothetical reactions of 2,5-RD and 1,2-DAB with
amino acids and proteins (R-NH2), forming pyrrole (DeCaprio et al., 1982) and
isoindole adducts, respectively. Chromogenicity is related to the first or second step
of polymer formation: at pH -7, 2,5-RD forms a yellow chromophore and 1,2-
DAB a purple-blue chromophore.
A prominent feature of proximal neurofilamentous axonopathies is the
segregation of microtubules that penetrate amassed neurofilaments in giant axonal
swellings. This is seen in the peripheral nerves of rats systemically treated with
2,5-HD or IDPN and can also be reproduced by local application or intraneural
injection of high concentrations of either agent to intact sciatic nerves in living
animals (Zagoren et al., 1983; Griffin et al., 1983). We have observed(data not
shown)a similar phenomenon after systemic treatment of rats with 1,2-DAB (10-
20 mg/g/d i.p.).Western blot analysis of intrafascicular nerve tissue showed that
NF-M was more sensitive than 13-tubulin to 1,2-DAB-induced cross-linking.70
Similarly, in spinal cordin vitro,NF-H and NF-M were more sensitive than
13-
tubulin to 1,2-DAB. Mice heterozygous or homozygous for the NF-H null mutation
fail to develop neurofilamentous swellings and segregated microtubules in motor
neurons after systemic IDPN treatment. These results indicate that the NF-H
subunit is a key mediator of IDPN-induced axonopathy (Zhu et al., 1998).
Whether IDPN (like 1,2-DAB) is related to lysine reactivity in this lysine-rich NF
subunit is unknown. While these data suggest that specific NF subunits are
preferentially targeted by both compounds, application of a high concentration of
1,2-DAB (0.2M, a saturated solution) or 2,5-HID (8M) to intact sciatic nerve for 5
mm to 2h induced microtubule aggregation only in the latter(data not shown).The
explanation for this unexpected negative result is not apparent.
It is important to emphasize that neuropathological changes (proximal
axonal swellings and microtubule segregation) in 1,2-DAB-induced radiculopathy
are seen in the absence of overt nerve fiber atrophy and axonal degeneration in the
more distally located peripheral nerves. These two phenomena are likely to be
unrelated to the mechanisms underlying the apparent arrest of slow anterograde NF
transport. Study of animals treated with 2,5-HD or IDPN demonstrate that
prominent nerve fiber atrophy occurs distal to NF-filled swellings in which fast
anterograde axonal transport is maintained (Griffin et al., 1978; Spencer and
Griffin, 1982). The recent suggestion of LoPachin (2000) that nerve fiber atrophy,
not giant axonal swelling, is a more prominent hallmark of aliphatic y-diketone
axonopathy is based on studies of animals treated with large doses of 2,5-HID in
which proximal regions (spinal roots) were not examined for the presence or
absence of NF-filled swellings. Single teased nerve fibers reveal that distal,
wallerian-like degeneration also occurs below focal nerve fiber swellings in 2,5-I-ID
axonopathy (Spencer and Schaumburg, 1977a). However, it is clear from more
recent studies that the trigger for wallenan degeneration is unrelated to NFs. This
is evident from the presence of 2,5-HD-induced peripheral nerve degeneration in
both wild-type and transgenic mice lacking genes coding for NF triplet proteins
(Stone et al., 1999, 2001). The precise trigger for the onset of distal axonal71
degeneration in y-diketone axonopathy is unknown: possibilities include (a)
chemical modification of motor or other proteins involved in axonal transport or (b)
the accumulation of axonal organelles, release of their calcium-rich contents into
the axoplasm, and activation of calcium-dependent calpains that destroy local axon
integrity protein (Spencer et al., 2001a,b). While the mechanism underlying axonal
degeneration is an important question to resolve, the 1,2-DAB radiculopathy model
shows that proximal giant axonal swelling(niaxonal atrophy or degeneration)
correlates with the onset of marked limb dysfunction.72
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Chapter 4
Conclusion
These studies with 1,2-diacetylbenzene (1,2-DAB) have increased
knowledge on the neurotoxicity of aromatic hydrocarbons as follows:
(1) A specific aromatic hydrocarbon structure (1,2-DAB) has been shown
to cause neurotoxicity.
(2) Molecular and cellular targets of 1,2-DAB have been identified.
(3) 1,2-DAB has been shown to induce neurofilamentous axonopathy.
(4) Aliphatic y-diketone 2,5-HID and aromatic y-diketone 1,2-DAB share
similar mechanisms of neurotoxicity.
Several widely used aromatic hydrocarbon solvents reportedly induce
blue-green discoloration of tissue and urine in animals and humans. The
chromophore is proposed to result from an isoindole reaction with amino groups in
proteins (Nan'ya and Maekawa, 1977a,b; Kim et al., 2001).
1,2-DAB, the putative metabolite of 1,2-DEB, behaves as a neurotoxic
substance. Animals treated with 1,2-DAB developed limb weakness associated
with proximal giant axonal swellings filled with lOnm neurofilaments.
Neurofilaments accumulated in the neuronal soma, intraspinal regions, proximal
ventral roots of peripheral motor axons and dorsal roots (Kim et al., 1999).
Continued treatment of rats with 1,2-DAB results in primary axonal degeneration
followed by secondary vacuolar demyelination of spinal roots indistinguishable
from the neuropathology associated with chronic treatment with musk tetralin
(Spencer et al., 1979a,b, 1980a).74
The chromogenicity of 1,2-DAB was related to neurotoxicity but these
properties were apparently not induced not related to a ninhydrin reaction.
Ninhydrin-treated rats failed to develop blue discoloration of internal organs and
showed no neurological symptoms. Ninhydrin did not form higher molecular
weight bands with neuronal and non-neural proteins.
The blue chromogen induced by treatment with 1,2-DAB can be used as a
possible urinary biomarker of exposure to aromatic solvents with neurotoxic
potential. Biomarkers can alert one to avoid exposure to specific substances, as
well as offering an early warning to avoid further exposure.
The structural relationships (y-diketone) and neurotoxic effects
(neurofilamentous axonopathy) shared by 1,2-DAB, DMHD, 3-methyl-
2,5-hexanedione, and 2,5-HID suggest the possibility of similar molecular
mechanisms. 1,2-DAB, compared with 2,5-HD, showed high protein reactivity and
neurotoxic potency. Much lower concentrations of 1,2-DAB versus 2,5-HD were
required to reduce native protein and form polymers with BSA, ribonuclease or NF
proteins.
Neuronal proteins were differentially reactive with 1,2-DAB. In the western
blot of the spinal cord treated with 1,2-DAB in vitro, NF-H and NF-M were more
sensitive than 3-tubu1in. Similarly, sciatic nerve tissue treated with 1,2-DAB
showed that NF-M was more sensitive than 3-tubulin.
The common amino acid, protein reactivity and comparable
neurofilamentous pathology associated with 1,2-DAB and 2,5-HID, suggests that
the neurotoxic properties of these two gamma diketones develop by common
mechanisms. In particular, other compounds, such as 1DPN induce comparable
patterns of axonal degeneration. The potent 3,4-dimethylated derivative of 2,5-HD
(DMIHD) to produce a similar spatial-temporal pattern of nerve damage (Fig. 4.1).
In summary, this study has identified the molecular and cellular targets of
1,2-DAB in the central and peripheral nervous system of rats. The results reported
in this thesis are expected to enhance our understanding of the toxic properties of
other chromogenic aromatic hydrocarbons, such as tetralin and hydroxyquinone* 1
Normal Fiber
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Figure 4.1. Sequence of CNS and PNS nerve fiber pathology: Repeated systemic
treatment with 1,2-diacetylbenzene induces the formation of proximal
giant axonal swellings (*) containing excessive members of
neurofilament. The affected region undergoes myelin splitting and
phagocytosis. Subsequently the axon undergoes local segmental
demyelination and remyelination (not shown)fbi
Since 1,2-DAB targets a broad spectrum of proteins, it is likely that several
other targets contribute to the neuropathologic response to this compound. Since
these targets may be selected in part on the basis of their lysine contents, future
studies ought to seek to determine, on this basis of this property, other molecular
targets by 1,2-DAB. Other functions that might be relevant are the longevity of
proteins and their need for transport run great distances with cells such as neurons.
Specific protein targets could also be examined using microarray and proteomic
techniques to determine 1,2-DAB vs. 1,3-DAB-induced change in transcription and
translation.77
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